https://www.interpharma.ch/fr/blog/johnson-johnson-sustainable-today-healthy-tomorrow/ 2026-02-26T07:37:42+00:00 https://www.interpharma.ch/wp-content/uploads/2023/02/janssen-SDG-2023-scaled.jpg https://www.interpharma.ch/fr/blog/blogserie-animal-welfare-report-2022-teil-1-notwendige-tierversuche-und-die-uebertragbarkeit-der-ergebnisse-auf-den-menschen/ 2026-02-26T07:38:10+00:00 https://www.interpharma.ch/wp-content/uploads/2022/11/AWR-22-Website-1.jpg https://www.interpharma.ch/fr/blog/la-protection-de-la-propriete-intellectuelle-nest-pas-le-probleme-mais-plutot-la-solution-interview-avec-rene-buholzer-en-agefi/ 2026-02-26T07:38:47+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/blog-image-066-scaled.jpg https://www.interpharma.ch/fr/blog/medienmitteilung-europabefragung-2022-die-schweizer-bevoelkerung-zeigt-sich-offen-fuer-einen-kompromiss/ 2026-02-26T07:39:15+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/bild_schweiz-EU_kachel_380x150.jpg https://www.interpharma.ch/fr/blog/pharmaindustrie-zeigt-sich-solidarisch-mit-der-bevoelkerung-in-der-ukraine/ 2026-02-26T07:39:16+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/blog-image-058-scaled.jpg https://www.interpharma.ch/fr/blog/medienmitteilung-ein-starkes-bekenntnis-zum-forschungsstandort-schweiz/ 2026-02-26T07:39:18+00:00 https://www.interpharma.ch/wp-content/uploads/2020/05/Bundeshaus-scaled.jpg https://www.interpharma.ch/fr/blog/3-fragen-an-joerg-storre-geschaeftsfuehrer-general-manager-von-vifor-pharma-schweiz/ 2026-02-26T07:39:21+00:00 https://www.interpharma.ch/wp-content/uploads/2021/12/Joerg-Storre.jpg https://www.interpharma.ch/fr/blog/update-projekte-und-massnahmen-forschender-pharma-unternehmen-gegen-die-coronavirus-epidemie-covid-19-2/ 2026-02-26T07:39:55+00:00 https://www.interpharma.ch/wp-content/uploads/2020/03/Corona-scaled.jpg https://www.interpharma.ch/wp-content/uploads/2020/03/test.jpg https://www.interpharma.ch/fr/blog/grosse-molekuele-grosse-wirkung-was-sind-biopharmazeutika/ 2026-02-26T07:40:30+00:00 https://www.interpharma.ch/wp-content/uploads/2021/04/ASS-vs.-IgG-Antik%C3%B6rper.jpg https://www.interpharma.ch/wp-content/uploads/2025/04/Bild-franzoesisch.png https://www.interpharma.ch/fr/blog/serie-animal-welfare-teil-2-massstaebe-setzen-zehn-jahre-animal-welfare-charta/ 2026-02-26T07:40:52+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/blog-image-072-scaled.jpg https://www.interpharma.ch/fr/blog/notre-engagement-dans-cette-situation-particuliere/ 2026-02-26T08:14:41+00:00 https://www.interpharma.ch/wp-content/uploads/2020/07/Vorschaubild_Kreislauf.jpg https://www.interpharma.ch/wp-content/uploads/2020/03/low_interpharma_leporello_rz_de-1.pdf https://www.interpharma.ch/wp-content/uploads/2020/03/low_interpharma_leporello_rz_en-pdf.jpg https://www.interpharma.ch/wp-content/uploads/2020/03/low_interpharma_leporello_rz_fr-pdf-1.jpg https://www.interpharma.ch/wp-content/uploads/2020/03/low_interpharma_leporello_rz_fr.pdf https://www.interpharma.ch/wp-content/uploads/2020/03/markus_ziegler.jpeg https://www.interpharma.ch/fr/blog/probablement-la-place-de-sciences-de-la-vie-la-plus-productive-au-monde/ 2026-02-26T08:18:10+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/bild_produktionsstandort_header_1280x380.jpg https://www.interpharma.ch/fr/blog/malgre-la-crise-du-coronavirus-les-suisses-souhaitent-des-relations-bien-reglees-avec-lue/ 2026-02-26T08:19:05+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/bild_schweiz-EU_kachel_380x150.jpg https://www.interpharma.ch/fr/blog/mise-a-jour-projets-et-mesures-dentreprises-pharmaceutiques-pratiquant-la-recherche-contre-lepidemie-de-coronavirus-et-de-covid-19/ 2026-02-26T08:22:03+00:00 https://www.interpharma.ch/wp-content/uploads/2020/03/Corona-scaled.jpg https://www.interpharma.ch/fr/blog/samuel-lanz-devient-le-nouveau-responsable-de-la-communication-dinterpharma/ 2026-02-26T08:23:47+00:00 https://www.interpharma.ch/wp-content/uploads/2020/04/SLanz.jpg https://www.interpharma.ch/fr/blog/maitrise-des-couts-lindustrie-pharmaceutique-accepte-les-modeles-de-prix-pour-autant-que-lacces-des-patient-e-s-sameliore/ 2026-02-26T09:31:01+00:00 https://www.interpharma.ch/wp-content/uploads/2022/12/Komplexitaet_iStock-1061344204.jpg https://interpharma.ch/wp-content/uploads/2022/12/Komplexitaet_iStock-1061344204-1024x683.jpg https://www.interpharma.ch/fr/blog/3-questions-a-la-nouvelle-responsable-du-comite-marche-myriam-deleone-directrice-generale-damgen-suisse/ 2026-02-26T09:31:02+00:00 https://www.interpharma.ch/wp-content/uploads/add-from-server-reloaded/L1040074-2-Bearbeitet-scaled-e1765550553239.jpg https://interpharma.ch/wp-content/uploads/2025/12/L1040074-2-Bearbeitet-1-683x1024.jpg https://www.interpharma.ch/fr/blog/communique-de-presse-le-conseil-federal-a-t-il-oublie-le-plus-grand-probleme-de-la-place-pharmaceutique-suisse/ 2026-02-26T09:31:03+00:00 https://www.interpharma.ch/wp-content/uploads/2023/10/Bundeshaus-klein.jpg https://www.interpharma.ch/fr/blog/communique-de-presse-la-suisse-devient-pays-de-reference-pour-les-prix-des-medicaments-aux-etats-unis-il-est-urgent-dagir/ 2026-02-26T09:31:04+00:00 https://www.interpharma.ch/wp-content/uploads/2025/08/iStock-1138801190_CH-USA.jpg https://www.interpharma.ch/fr/blog/serie-de-blogs-sur-le-moniteur-de-la-sante-2025-dinterpharma-partie-3-la-perception-des-couts-et-les-faits-ne-concordent-pas-toujours/ 2026-02-26T09:31:04+00:00 https://www.interpharma.ch/wp-content/uploads/2025/11/Screenshot-2025-11-03-090627.png https://interpharma.ch/wp-content/uploads/2025/11/image-4.png https://interpharma.ch/wp-content/uploads/2025/11/image-5.png https://www.interpharma.ch/fr/blog/serie-de-blogs-sur-le-moniteur-de-la-sante-2025-dinterpharma-partie-2-bonne-qualite-mais-potentiel-damelioration/ 2026-02-26T09:31:04+00:00 https://www.interpharma.ch/wp-content/uploads/2025/11/Screenshot-2025-11-03-090627.png https://interpharma.ch/wp-content/uploads/2025/11/image.png https://interpharma.ch/wp-content/uploads/2025/11/image-1.png https://www.interpharma.ch/fr/blog/serie-de-blogs-sur-le-moniteur-de-la-sante-2025-dinterpharma-partie-1-un-quart-de-siecle/ 2026-02-26T09:31:04+00:00 https://www.interpharma.ch/wp-content/uploads/2025/11/Screenshot-2025-11-03-090627.png https://www.interpharma.ch/fr/blog/communique-de-presse-nouvelle-contribution-significative-de-la-pharma-a-la-maitrise-des-couts-quand-la-securite-dapprovisionnement-est-menacee/ 2026-02-26T09:31:04+00:00 https://www.interpharma.ch/wp-content/uploads/2025/07/iStock-1944747642.jpg https://interpharma.ch/wp-content/uploads/2025/10/image-2-1024x123.png https://www.interpharma.ch/fr/blog/innovation-numerique-chez-takeda-entretien-avec-jerome-veyret-head-of-business-excellence-strategy-transformation/ 2026-02-26T09:31:05+00:00 https://www.interpharma.ch/wp-content/uploads/2025/10/Jerome-Veyret-scaled.jpg https://www.interpharma.ch/fr/blog/communique-de-presse-nouvelle-enquete-sur-leurope-2025-les-intentions-de-vote-sur-les-accords-bilateraux-iii-montrent-une-large-majorite-de-oui/ 2026-02-26T09:31:05+00:00 https://www.interpharma.ch/wp-content/uploads/2025/09/Screenshot-2025-09-09-105829.png https://www.interpharma.ch/fr/blog/communique-de-presse-pour-la-suisse-lheure-est-grave-il-faut-a-present-une-offensive-pour-la-place-suisse/ 2026-02-26T09:31:05+00:00 https://www.interpharma.ch/wp-content/uploads/2025/08/iStock-1138801190_CH-USA.jpg https://www.interpharma.ch/fr/blog/value-based-healthcare-pourquoi-nous-devrions-avoir-le-courage-de-repenser-le-systeme-de-sante/ 2026-02-26T09:31:05+00:00 https://www.interpharma.ch/wp-content/uploads/2025/06/Screenshot-2025-06-05-130443.png https://www.interpharma.ch/fr/blog/communique-de-presse-acces-aux-nouveaux-medicaments-la-suisse-continue-de-perdre-du-terrain-la-prise-en-charge-des-patient-e-s-et-la-place-suisse-sont-en-danger/ 2026-02-26T09:31:06+00:00 https://www.interpharma.ch/wp-content/uploads/2021/02/iStock-1064859060-scaled.jpg https://www.interpharma.ch/fr/blog/medienmitteilung-bilaterale-iii-exportstandort-sichern-fuer-eine-international-vernetzte-souveraene-schweiz/ 2026-02-26T09:31:06+00:00 https://www.interpharma.ch/fr/blog/3-questions-a-nos-nouveaux-membres-du-conseil-dadministration-iris-zemzoum-president-region-europe-chez-novartis-et-vice-president-du-conseil-dadministration/ 2026-02-26T09:31:06+00:00 https://www.interpharma.ch/wp-content/uploads/2025/06/Beitragsbild_3-Fragen-an-Iris-Zemzoum.png https://interpharma.ch/wp-content/uploads/2025/06/Photo-Iris-Zemzoum.jpg https://www.interpharma.ch/fr/blog/communique-de-presse-bilaterales-iii-relations-stables-avec-le-principal-partenaire-commercial/ 2026-02-26T09:31:06+00:00 https://www.interpharma.ch/wp-content/uploads/2024/03/CH_EU_generisch-klein-scaled.jpg https://www.interpharma.ch/fr/blog/communique-de-presse-lindustrie-pratiquant-la-recherche-prend-note-de-la-conclusion-de-laccord-de-libre-echange-avec-le-mercosur/ 2026-02-26T09:31:06+00:00 https://www.interpharma.ch/wp-content/uploads/2025/07/EFTA-Mercosur.jpg https://interpharma.ch/wp-content/uploads/2025/07/image.png https://www.interpharma.ch/fr/blog/production-pharma-de-pointe-en-suisse-assurer-linnovation-maintenir-la-competitivite/ 2026-02-26T09:31:06+00:00 https://www.interpharma.ch/wp-content/uploads/2025/06/Bild-DE.png https://www.interpharma.ch/fr/blog/communique-de-presse-concentration-sur-la-qualite-plutot-que-la-quantite-comment-le-value-based-healthcare-peut-assurer-la-perennite-du-systeme-de-sante-suisse/ 2026-02-26T09:31:07+00:00 https://www.interpharma.ch/wp-content/uploads/2025/06/Titelbild_Value-based-Healthcare.png https://interpharma.ch/wp-content/uploads/2025/06/image.png https://www.interpharma.ch/fr/blog/3-fragen-an-unsere-neuen-boardmitglieder-florian-saur-country-general-manager-switzerland-astrazeneca/ 2026-02-26T09:31:07+00:00 https://www.interpharma.ch/wp-content/uploads/2025/06/AZ_Florian-Saur_1-scaled.jpg https://interpharma.ch/wp-content/uploads/2025/06/AZ_Florian-Saur_1-1024x683.jpg https://www.interpharma.ch/fr/blog/3-questions-a-nos-nouveaux-membres-du-conseil-dadministration-annette-luther-head-external-affairs-switzerland-chez-roche/ 2026-02-26T09:31:07+00:00 https://www.interpharma.ch/wp-content/uploads/2025/05/Beitragsbild_Annette-Luther_3-Fraqgen-an.png https://interpharma.ch/wp-content/uploads/2025/05/Annette_Luther_Roche_02-819x1024.jpg https://www.interpharma.ch/fr/blog/3-questions-a-nos-nouveaux-membres-du-conseil-dadministration-linn-mandahl-vice-president-europe-region-south-chez-abbvie/ 2026-02-26T09:31:07+00:00 https://www.interpharma.ch/wp-content/uploads/2025/05/Beitragsbild-3-Fragen-an-Linn-Mandahl-1.png https://interpharma.ch/wp-content/uploads/2025/05/Linn-Mandahl-1-683x1024.jpg https://www.interpharma.ch/fr/blog/3-questions-a-nos-nouveaux-membres-du-comite-david-traub-directeur-de-novartis-pharma-schweiz-ag/ 2026-02-26T09:31:08+00:00 https://www.interpharma.ch/wp-content/uploads/2025/05/Beitragsbild-3-Fragen-an-David-Traub-1.png https://interpharma.ch/wp-content/uploads/2025/05/David-Traub-748x1024.jpg https://www.interpharma.ch/fr/blog/le-contre-projet-a-linitiative-pour-un-frein-aux-couts-fait-fi-de-la-decision-du-parlement-et-renforce-la-pensee-en-silos/ 2026-02-26T09:31:08+00:00 https://www.interpharma.ch/wp-content/uploads/2023/10/Bundeshaus-klein.jpg https://www.interpharma.ch/fr/blog/lintegration-des-medicaments-innovants-dans-les-forfaits-ambulatoires-met-en-danger-la-qualite-et-linnovation/ 2026-02-26T09:31:08+00:00 https://www.interpharma.ch/wp-content/uploads/2025/04/iStock-529498283_Gesundheitswesen-und-Kosten.jpg https://www.interpharma.ch/fr/blog/medienmitteilung-standortwettbewerb-verschaerft-sich-jetzt-braucht-es-eine-schweizer-life-science-strategie/ 2026-02-26T09:31:08+00:00 https://www.interpharma.ch/wp-content/uploads/2022/03/iStock-1293772969.jpg https://www.interpharma.ch/fr/blog/la-prevention-dans-le-systeme-de-sante-suisse/ 2026-02-26T09:31:08+00:00 https://www.interpharma.ch/wp-content/uploads/2025/04/Bildschirmfoto-2022-03-21-um-11.51.57-1.jpg https://interpharma.ch/wp-content/uploads/2025/04/Bildschirmfoto-2022-03-21-um-11.51.57-1024x594.jpg https://www.interpharma.ch/fr/blog/acces-a-linnovation-dans-les-domaines-de-la-prevention-et-du-depistage-precoce/ 2026-02-26T09:31:09+00:00 https://www.interpharma.ch/wp-content/uploads/2025/04/iStock_Herz_Praevention.jpg https://www.interpharma.ch/fr/blog/lutilisation-des-donnees-comme-cle-dune-prevention-plus-ciblee/ 2026-02-26T09:31:09+00:00 https://www.interpharma.ch/wp-content/uploads/2025/04/NF_AI4HealthyCities_Skyline_Banner-scaled.jpg https://www.interpharma.ch/fr/blog/strategie-et-coordination-globales/ 2026-02-26T09:31:09+00:00 https://www.interpharma.ch/wp-content/uploads/2025/04/Bild_Blogbeitrag-2.png https://www.interpharma.ch/fr/blog/une-prevention-ciblee-et-une-detection-precoce-comme-cles-de-la-reussite-a-long-terme/ 2026-02-26T09:32:09+00:00 https://www.interpharma.ch/wp-content/uploads/2025/04/Beitragsbild-deutsch.png https://www.interpharma.ch/fr/blog/la-prevention-comme-element-dun-systeme-de-sante-suisse-perenne/ 2026-02-26T09:32:11+00:00 https://www.interpharma.ch/wp-content/uploads/2025/04/Prinzipien-des-Gesundheitswesens_slide-scaled.png https://www.interpharma.ch/fr/blog/journee-de-lindustrie-pharmaceutique-2025-renforcer-la-competitivite-de-lindustrie-pharmaceutique-suisse/ 2026-02-26T09:32:11+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/bild_schweiz-EU_kachel_380x150.jpg https://www.interpharma.ch/fr/blog/medienmitteilung-daiichi-sankyo-wird-mitglied-bei-interpharma/ 2026-02-26T09:32:11+00:00 https://www.interpharma.ch/wp-content/uploads/2025/04/Ausschnitt-Jahresbericht-2024.jpg https://www.interpharma.ch/fr/blog/2e-volet-de-mesures-visant-a-freiner-la-hausse-des-couts-un-bilan-extremement-douteux/ 2026-02-26T09:32:11+00:00 https://www.interpharma.ch/wp-content/uploads/2023/09/KP2_klein.png https://www.interpharma.ch/fr/blog/medienmitteilung-europabefragung-2025-die-schweizer-bevoelkerung-befuerwortet-das-ergebnis-der-verhandlungen-mit-der-eu-trotz-einiger-unsicherheiten/ 2026-02-26T09:32:11+00:00 https://www.interpharma.ch/wp-content/uploads/2025/03/Web-Europabefragung-2025.jpg https://www.interpharma.ch/fr/?p=12162 2026-02-26T09:32:11+00:00 https://www.interpharma.ch/wp-content/uploads/2025/02/Manuela-Stier_Bild-2.jpg https://interpharma.ch/wp-content/uploads/2025/02/Manuela-Stier_Bild-1-672x1024.jpg https://www.interpharma.ch/fr/blog/la-croissance-du-secteur-des-medicaments-recule-les-copies-de-produits-originaux-gagnent-enormement-de-terrain/ 2026-02-26T09:32:11+00:00 https://www.interpharma.ch/wp-content/uploads/2023/01/Medikamentenproduktion.jpg https://www.interpharma.ch/fr/blog/communique-de-presse-carte-blanche-de-la-commission-du-conseil-des-etats-a-ladministration-acces-aux-medicaments-en-danger/ 2026-02-26T09:32:11+00:00 https://www.interpharma.ch/wp-content/uploads/2023/09/KP2_klein.png https://www.interpharma.ch/fr/blog/lung-on-chip-eine-humane-loesung-zur-pruefung-von-lungenfunktion-und-toxizitaet/ 2026-02-26T09:32:12+00:00 https://www.interpharma.ch/wp-content/uploads/2025/01/2021-3RCC-026-scaled.jpg https://www.interpharma.ch/fr/blog/la-suisse-ne-doit-avoir-de-cesse-de-sameliorer/ 2026-02-26T09:32:12+00:00 https://www.interpharma.ch/wp-content/uploads/2025/01/thm_DE2.png https://www.interpharma.ch/fr/blog/medienmitteilung-verhandlungsabschluss-zu-den-bilateralen-iii-ein-wichtiger-schritt-fuer-die-sicherung-von-wohlstand-und-innovationskraft-der-schweiz/ 2026-02-26T09:32:12+00:00 https://www.interpharma.ch/wp-content/uploads/2024/03/CH_EU_generisch-klein-scaled.jpg https://www.interpharma.ch/fr/blog/douloureuses-economies-pour-lindustrie-pharmaceutique-le-conseil-national-envoie-un-signal-en-faveur-de-la-securite-de-lapprovisionnement/ 2026-02-26T09:32:12+00:00 https://www.interpharma.ch/wp-content/uploads/2023/09/KP2_klein.png https://www.interpharma.ch/fr/blog/medienmitteilung-einreichung-der-unterschriftenlisten-ja-zur-tierversuchsfreien-zukunft-ein-erneuter-angriff-auf-den-forschungsstandort-schweiz/ 2026-02-26T09:32:14+00:00 https://www.interpharma.ch/wp-content/uploads/2022/03/iStock-1293772969.jpg https://www.interpharma.ch/fr/blog/blogserie-mit-dem-3rcc-teil-9-neue-therapien-im-fokus-wie-bahnbrechende-tierversuchsfreie-forschung-den-weg-zur-behandlung-der-fettleber-ebnet/ 2026-02-26T09:32:14+00:00 https://www.interpharma.ch/wp-content/uploads/2024/11/BIld-Artikel-9-Liver_organoid-scaled.jpg https://www.interpharma.ch/fr/blog/blogserie-mit-dem-3rcc-teil-8-koennen-insekten-emotionen-empfinden-neue-studien-entfachen-eine-debatte-ueber-die-schmerzempfindlichkeit-wirbelloser-lebewesen/ 2026-02-26T09:32:14+00:00 https://www.interpharma.ch/wp-content/uploads/2024/10/Artikel-8-AdobeStock_741829926-scaled.jpeg https://www.interpharma.ch/fr/blog/medienmitteilung-kostendaempfungspaket-2-erneut-einschneidende-sparmassnahmen-zulasten-der-pharmaindustriemedienmitteilung/ 2026-02-26T09:32:14+00:00 https://www.interpharma.ch/wp-content/uploads/2023/09/KP2_klein.png https://www.interpharma.ch/fr/blog/blogserie-mit-dem-3rcc-teil-7-neue-methode-simuliert-echte-gewebestrukturen-ein-grosser-schritt-fuer-die-zukunft-der-krebsforschung/ 2026-02-26T09:32:14+00:00 https://www.interpharma.ch/wp-content/uploads/2024/10/Artikel-7-pdac_ck7_dapi_day13.png https://www.interpharma.ch/fr/blog/financement-uniforme-pour-un-systeme-de-sante-plus-juste-et-plus-efficace/ 2026-02-26T09:32:14+00:00 https://www.interpharma.ch/wp-content/uploads/2024/10/ef-header.jpg https://interpharma.ch/wp-content/uploads/2024/10/20240925_EF_Grafik-2_DE_01-1024x455.jpg https://www.interpharma.ch/fr/blog/versorgungssicherheit-in-der-schweiz-herausforderungen-und-strategien-fuer-die-zukunft/ 2026-02-26T09:32:14+00:00 https://www.interpharma.ch/wp-content/uploads/2024/10/Titelbild.jpg https://interpharma.ch/wp-content/uploads/2024/09/Bild1-1024x700.png https://interpharma.ch/wp-content/uploads/2024/09/Bild2-1-1024x767.png https://www.interpharma.ch/fr/blog/blogserie-mit-dem-3rcc-teil-6-wachstumswunder-wie-radial-verteilte-stammzellen-das-wachstum-von-organoiden-foerdern/ 2026-02-26T09:32:14+00:00 https://www.interpharma.ch/wp-content/uploads/2024/09/Bild-Artikel-6-OCTOPUS-THUMBNAIL.png https://www.interpharma.ch/fr/blog/hightech-pharmaproduktion-in-der-schweizer-pharmaindustrie-innovation-und-effizienz/ 2026-02-26T09:32:15+00:00 https://www.interpharma.ch/wp-content/uploads/2020/08/APV-Bild2.png https://www.interpharma.ch/fr/blog/naeher-an-der-loesung-des-praeeklampsie-raetsels-in-vitro-trophoblastzellen-in-aktion/ 2026-02-26T09:32:15+00:00 https://www.interpharma.ch/wp-content/uploads/2024/09/2023-Swiss3RCC-003-low.jpg https://www.interpharma.ch/fr/blog/communique-de-presse-panorama-de-la-sante-2024-contribution-factuelle-au-dialogue-en-faveur-dun-systeme-de-sante-davenir/ 2026-02-26T09:32:15+00:00 https://www.interpharma.ch/wp-content/uploads/2024/08/Front-DE.png https://interpharma.ch/wp-content/uploads/2024/08/In-Kuerze-1024x666.png https://www.interpharma.ch/fr/?p=12310 2026-02-26T09:32:15+00:00 https://www.interpharma.ch/wp-content/uploads/2024/06/Titelbild-Gesundheitsmonitor-2024-D.jpg https://www.interpharma.ch/fr/blog/medienmitteilung-europabefragung-2024-die-schweizer-stimmbevoelkerung-steht-klar-hinter-den-bilateralen-und-zeigt-sich-kompromissbereit/ 2026-02-26T09:32:15+00:00 https://www.interpharma.ch/wp-content/uploads/2024/03/CH_EU_generisch-klein-scaled.jpg https://www.interpharma.ch/fr/blog/sommerblogserie-zusammen-mit-dem-3rcc-teil-3-das-gehirn-und-die-zeit-was-fruchtfliegen-uns-verraten/ 2026-02-26T09:32:15+00:00 https://www.interpharma.ch/wp-content/uploads/2024/08/FlyCircadianRhythm.png https://interpharma.ch/wp-content/uploads/2024/08/FlyCircadianRhythm-1024x576.png https://www.interpharma.ch/fr/blog/communique-de-presse-2e-volet-de-mesures-visant-a-freiner-la-hausse-des-couts-la-commission-de-la-sante-du-national-procede-a-des-rectifications-importantes/ 2026-02-26T09:32:15+00:00 https://www.interpharma.ch/wp-content/uploads/2023/09/KP2_klein.png https://www.interpharma.ch/fr/blog/serie-de-blogs-sur-le-moniteur-de-la-sante-2024-dinterpharma-partie-2-la-population-suisse-apprecie-la-qualite-du-systeme-de-sante-suisse/ 2026-02-26T09:32:15+00:00 https://www.interpharma.ch/wp-content/uploads/2024/06/Titelbild-Gesundheitsmonitor-2024-D.jpg https://interpharma.ch/wp-content/uploads/2024/08/image-3.png https://interpharma.ch/wp-content/uploads/2024/08/image.png https://interpharma.ch/wp-content/uploads/2024/08/image-1.png https://interpharma.ch/wp-content/uploads/2024/08/image-2.png https://www.interpharma.ch/fr/blog/sommerblogserie-mit-dem-3rcc-teil-5-3d-gedrucktes-modell-revolutioniert-die-krebsforschung/ 2026-02-26T09:32:15+00:00 https://www.interpharma.ch/wp-content/uploads/2024/09/iStock-1530776415.jpg https://www.interpharma.ch/fr/blog/blogserie-interpharma-gesundheitsmonitor-2024-teil-1-zunehmender-roestigraben-bei-gesundheitsfragen/ 2026-02-26T09:32:16+00:00 https://www.interpharma.ch/wp-content/uploads/2024/06/Titelbild-Gesundheitsmonitor-2024-D.jpg https://interpharma.ch/wp-content/uploads/2024/08/Bild1.png https://interpharma.ch/wp-content/uploads/2024/08/Bild2-1024x676.png https://interpharma.ch/wp-content/uploads/2024/08/Bild3-1024x672.png https://interpharma.ch/wp-content/uploads/2024/08/Bild4-1024x674.png https://www.interpharma.ch/fr/blog/sommerblogserie-zusammen-mit-dem-3rcc-teil-2-erforschung-von-blutstammzellen-erkenntnisse-aus-bildgebenden-verfahren-ueber-die-entwicklung-von-zebrafischen/ 2026-02-26T09:32:16+00:00 https://www.interpharma.ch/wp-content/uploads/2024/07/Zebrafisch.png https://www.interpharma.ch/fr/blog/communique-de-presse-lapprovisionnement-en-medicaments-est-en-danger-le-marche-suisse-perd-de-son-attrait/ 2026-02-26T09:32:16+00:00 https://www.interpharma.ch/wp-content/uploads/2024/07/Therapie.jpg https://interpharma.ch/wp-content/uploads/2024/07/Benchmarking_DE-1024x519.png https://www.interpharma.ch/fr/blog/sommerblogserie-zusammen-mit-dem-3rcc-teil-1-wie-darmbakterien-das-sozialverhalten-von-zebrafischen-beeinflussen/ 2026-02-26T09:32:16+00:00 https://www.interpharma.ch/wp-content/uploads/2024/07/Zebrafisch.png https://interpharma.ch/wp-content/uploads/2024/07/Zebrafisch.png https://www.interpharma.ch/fr/blog/3-fragen-an-unsere-neuen-boardmitglieder-florian-schick-president-merck-switzerland/ 2026-02-26T09:32:17+00:00 https://www.interpharma.ch/wp-content/uploads/2024/07/Schick_1_klein.jpg https://interpharma.ch/wp-content/uploads/2024/07/Schick_1-1024x1024.jpg https://www.interpharma.ch/fr/blog/communique-de-presse-les-patientes-et-patients-font-les-frais-des-decisions/ 2026-02-26T09:32:17+00:00 https://www.interpharma.ch/wp-content/uploads/2023/09/KP2_klein.png https://www.interpharma.ch/fr/blog/communique-de-presse-le-conseil-des-etats-met-en-danger-lacces-des-patient-e-scommunique-de-presse/ 2026-02-26T09:32:17+00:00 https://www.interpharma.ch/wp-content/uploads/2023/09/KP2_klein.png https://www.interpharma.ch/fr/blog/interpharma-gesundheitsmonitor-2024-zeigt-roesti-graben-bei-gesundheitsfragen-in-der-schweizer-bevoelkerung/ 2026-02-26T09:32:17+00:00 https://www.interpharma.ch/wp-content/uploads/2024/06/Titelbild-Gesundheitsmonitor-2024-D.jpg https://www.interpharma.ch/fr/blog/communique-de-presse-disponibilite-des-medicaments-la-suisse-perd-du-terrain/ 2026-02-26T09:32:17+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/blog-image-088-scaled.png https://interpharma.ch/wp-content/uploads/2024/06/wait-1024x558.png https://www.interpharma.ch/fr/blog/des-approches-globales-dans-le-systeme-de-sante-sont-plus-urgentes-que-jamais/ 2026-02-26T09:32:17+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/blog-image-087-scaled.png https://www.interpharma.ch/fr/blog/communique-de-presse-comparaison-de-prix-des-medicaments-avec-letranger-augmentation-de-lecart-differences-importantes-sur-les-generiques-et-les-biosimilaires/ 2026-02-26T09:32:18+00:00 https://www.interpharma.ch/wp-content/uploads/2024/05/Titelbild_MM_APV_D.jpg https://www.interpharma.ch/fr/blog/communique-de-presse-par-sa-decision-hative-sur-les-modeles-dimpact-budgetaire-la-commission-du-conseil-des-etats-met-en-danger-lacces-des-patient-e-s/ 2026-02-26T09:32:19+00:00 https://www.interpharma.ch/wp-content/uploads/2023/09/KP2_klein.png https://www.interpharma.ch/fr/blog/medienmitteilung-tag-der-pharmazeutischen-industrie-2024-was-es-fuer-ein-innovationsoekosystem-schweiz-braucht/ 2026-02-26T09:32:19+00:00 https://www.interpharma.ch/wp-content/uploads/2024/04/Titelbild-Jahresbericht-2023-D.png https://www.interpharma.ch/fr/blog/medienmitteilung-generalversammlung-von-interpharma-2/ 2026-02-26T09:32:19+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/blog-image-002.jpg https://www.interpharma.ch/fr/blog/medienmitteilung-interpharma-nimmt-den-abschluss-des-freihandelsabkommens-mit-indien-zur-kenntnis/ 2026-02-26T09:32:20+00:00 https://www.interpharma.ch/wp-content/uploads/2024/03/CH-INdien.jpg https://www.interpharma.ch/fr/blog/medienmitteilung-der-bilaterale-weg-soll-weitergehen/ 2026-02-26T09:32:20+00:00 https://www.interpharma.ch/wp-content/uploads/2024/03/CH_EU_generisch-klein-scaled.jpg https://www.interpharma.ch/fr/blog/medienmitteilung-interpharma-unterstuetzt-den-entwurf-des-verhandlungsmandats/ 2026-02-26T09:32:20+00:00 https://www.interpharma.ch/wp-content/uploads/2023/04/CH_EU_generisch-scaled.jpg https://www.interpharma.ch/fr/blog/communique-de-presse-croissance-du-marche-du-medicament-nettement-ralentie-par-les-baisses-de-prix/ 2026-02-26T09:32:21+00:00 https://www.interpharma.ch/wp-content/uploads/2023/01/Medikamentenproduktion.jpg https://www.interpharma.ch/fr/blog/medienmitteilung-die-pharmabranche-ist-der-motor-der-schweizer/ 2026-02-26T09:32:21+00:00 https://www.interpharma.ch/wp-content/uploads/2024/01/Bedeutungstudie-2024-D-Bild-MM.jpg https://www.interpharma.ch/fr/blog/communique-de-presse-etape-majeure-franchie-en-politique-de-la-sante-le-parlement-adopte-efas/ 2026-02-26T09:32:40+00:00 https://www.interpharma.ch/wp-content/uploads/2023/12/EFAS_Ja_Entscheid.jpeg https://www.interpharma.ch/fr/blog/medienmitteilung-breite-zustimmung-in-der-stimmbevoelkerung-fuer-ein-verhandlungsmandat-zu-den-bilateralen-iii/ 2026-02-26T09:32:40+00:00 https://www.interpharma.ch/wp-content/uploads/2023/12/Umfrsge-Europa-Bilaterale-3.jpg https://www.interpharma.ch/fr/blog/medienmitteilung-eu-verhandlungsmandat-ein-wichtiger-meilenstein-fuer-die-stabilisierung-der-bilateralen-beziehungen/ 2026-02-26T09:32:40+00:00 https://www.interpharma.ch/wp-content/uploads/2023/04/CH_EU_generisch-scaled.jpg https://www.interpharma.ch/fr/blog/communique-de-presse-marges-lindustrie-accepte-de-nouvelles-economies-mais-lacces-des-patients-est-en-danger/ 2026-02-26T09:32:40+00:00 https://www.interpharma.ch/wp-content/uploads/2022/09/iStock-170160380.jpg https://interpharma.ch/wp-content/uploads/2023/12/iph_panorama_D_S24-1024x683.png https://interpharma.ch/wp-content/uploads/2023/12/Bild1.png https://interpharma.ch/wp-content/uploads/2023/12/Bild2.png https://interpharma.ch/wp-content/uploads/2023/12/Bild3.png https://www.interpharma.ch/fr/blog/communique-de-presse-animal-welfare-report-2023-utiliser-la-transformation-numerique-de-la-recherche-sur-les-animaux-pour-faire-avancer-les-principes-des-3r/ 2026-02-26T09:32:40+00:00 https://www.interpharma.ch/wp-content/uploads/2023/11/Animal-Welfare.jpg https://www.interpharma.ch/fr/blog/medienmitteilung-digisante-eine-chance-um-den-rueckstand-bei-der-digitalisierung-des-schweizer-gesundheitswesens-aufzuholen/ 2026-02-26T09:32:41+00:00 https://www.interpharma.ch/wp-content/uploads/2023/11/Digitalisierung-allgemein-1-scaled.jpg https://www.interpharma.ch/fr/blog/communique-de-presse-un-cercle-dexperts-presente-les-exigences-envers-une-loi-cadre-sur-la-reutilisation-des-donnees/ 2026-02-26T09:32:42+00:00 https://www.interpharma.ch/wp-content/uploads/2020/09/Digitalisierung-allgemein-scaled.jpg https://www.interpharma.ch/fr/blog/elections-2023-evaluation-dinterpharma/ 2026-02-26T09:32:43+00:00 https://www.interpharma.ch/wp-content/uploads/2023/10/Bundeshaus-klein.jpg https://www.interpharma.ch/fr/blog/serie-sustainable-development-goals-johnson-johnson-engagiert-sich-fuer-klimaschutz-mit-konkreten-projekten/ 2026-02-26T09:32:43+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/blog-image-076-scaled.jpg https://www.interpharma.ch/fr/blog/communique-de-presse-deuxieme-volet-de-mesures-visant-a-freiner-la-hausse-des-couts-etape-importante-pour-lacces-des-patient-e-s-et-la-securite-dapprovisionnement/ 2026-02-26T09:32:43+00:00 https://www.interpharma.ch/wp-content/uploads/2023/09/KP2_klein.png https://www.interpharma.ch/fr/blog/communique-de-presse-revision-de-loamal-la-tactique-de-reduction-des-couts-menace-la-prise-en-charge-dans-les-cas-medicaux-exceptionnels/ 2026-02-26T09:32:43+00:00 https://www.interpharma.ch/wp-content/uploads/2023/09/Revision-KVVKLV_small-1.png https://www.interpharma.ch/fr/blog/panorama-de-la-sante-2023-puissions-nous-connaitre-90-annees-supplementaires-dinnovation-et-de-qualite-dans-le-domaine-de-la-sante/ 2026-02-26T09:32:43+00:00 https://www.interpharma.ch/wp-content/uploads/2023/08/Cover-DE.png https://interpharma.ch/wp-content/uploads/2023/08/Bullets-1.png https://www.interpharma.ch/fr/blog/communique-de-presse-il-faut-a-present-des-progres-rapides-pour-stabiliser-les-relations-bilaterales/ 2026-02-26T09:32:44+00:00 https://www.interpharma.ch/wp-content/uploads/2023/04/CH_EU_generisch-scaled.jpg https://www.interpharma.ch/fr/blog/medienmitteilung-gesundheitsmonitor-2023-zeigt-schweizer-bevoelkerung-fordert-einen-schnelleren-zugang-zu-innovativen-medikamenten/ 2026-02-26T09:32:44+00:00 https://www.interpharma.ch/wp-content/uploads/2023/06/Titelbild-d-Gesundheitsmonitor-2023.jpg https://www.interpharma.ch/fr/blog/internationaler-tag-der-klinischen-forschung-3-fragen-an-prof-dr-med-miklos-pless-praesident-sakk/ 2026-02-26T09:32:45+00:00 https://www.interpharma.ch/wp-content/uploads/2023/05/Pless-Miklos.jpg https://www.interpharma.ch/fr/blog/communique-de-presse-comparaison-du-prix-des-medicaments-avec-letranger-ecarts-de-prix-significatifs-pour-les-generiques-et-les-biosimilaires-legere-baisse-pour-les-preparations-o/ 2026-02-26T09:32:45+00:00 https://www.interpharma.ch/wp-content/uploads/2023/05/APV.png https://www.interpharma.ch/fr/blog/3-fragen-an-thorsten-hein-mitglied-interpharma-board-und-country-division-head-pharmaceuticals-bayer-schweiz/ 2026-02-26T09:32:45+00:00 https://www.interpharma.ch/wp-content/uploads/2021/11/ThorstenHein.neu_.png https://www.interpharma.ch/fr/blog/3-fragen-an-graham-dorey-mitglied-interpharma-board-und-general-manager-schweiz-biogen/ 2026-02-26T09:32:47+00:00 https://www.interpharma.ch/wp-content/uploads/2023/05/dorey_741_highres-1-scaled.jpg https://www.interpharma.ch/fr/blog/3-fragen-an-max-pahlow-mitglied-interpharma-board-und-managing-director-janssen-switzerland/ 2026-02-26T09:32:47+00:00 https://www.interpharma.ch/wp-content/uploads/2023/04/klein_MAX-PAHLOW18753.jpg https://www.interpharma.ch/fr/blog/medienmitteilung-ueberarbeitung-der-allgemeinen-eu-arzneimittelvorschriften-schwerwiegende-konsequenzen-fuer-die-schweiz-erwartet/ 2026-02-26T09:32:47+00:00 https://www.interpharma.ch/wp-content/uploads/2023/04/CH_EU_generisch-scaled.jpg https://www.interpharma.ch/fr/blog/3-fragen-an-pierre-morneau-general-manager-takeda-schweiz-takeda-pharma-ag-vice-chair-innovation-hub-committee/ 2026-02-26T09:32:47+00:00 https://www.interpharma.ch/wp-content/uploads/2023/04/896_Interpharma-scaled.jpg https://www.interpharma.ch/fr/blog/communique-de-presse-interpharma-90-ans-dinnovation-et-dengagement-au-service-des-patientes-et-patients-de-suisse/ 2026-02-26T09:32:48+00:00 https://www.interpharma.ch/wp-content/uploads/2023/03/Logo_90-Jahre.jpg https://www.interpharma.ch/fr/blog/medienmitteilung-generalversammlung-von-interpharma/ 2026-02-26T09:32:48+00:00 https://www.interpharma.ch/wp-content/uploads/2023/03/Jahresbericht-2022-Titelbild-D.jpg https://www.interpharma.ch/fr/blog/medienmitteilung-europabefragung-2023-schweizer-bevoelkerung-unterstuetzt-bilaterale-noch-staerker-und-erwartet-vom-bundesrat-einen-konkreten-vorschlag/ 2026-02-26T09:32:48+00:00 https://www.interpharma.ch/wp-content/uploads/2023/03/Europabefragung-2023.jpg https://www.interpharma.ch/fr/blog/johnson-johnson-sustainable-today-healthy-tomorrow/ 2026-02-26T09:32:48+00:00 https://www.interpharma.ch/wp-content/uploads/2023/02/janssen-SDG-2023-scaled.jpg https://www.interpharma.ch/fr/blog/communique-de-presse-croissance-du-marche-des-medicaments-a-nouveau-nettement-freinee-par-les-baisses-de-prix/ 2026-02-26T09:32:48+00:00 https://www.interpharma.ch/wp-content/uploads/2023/01/Medikamentenproduktion.jpg https://www.interpharma.ch/fr/blog/communique-de-presse-les-commissions-de-la-securite-sociale-et-de-la-sante-publique-du-conseil-national-et-du-conseil-des-etats-envoient-un-signal-fort-et-reconnaissent-aussi-une-necessite-d/ 2026-02-26T09:32:48+00:00 https://www.interpharma.ch/wp-content/uploads/2023/01/Revision-KVVKLV_small.png https://www.interpharma.ch/fr/blog/die-erosion-geht-weiter-der-bundesrat-sieht-keinen-handlungsbedarf-zur-staerkung-des-schweizer-pharmastandortes-leider/ 2026-02-26T09:32:48+00:00 https://www.interpharma.ch/wp-content/uploads/2020/05/Bundeshaus-scaled.jpg https://interpharma.ch/wp-content/uploads/2023/01/Blog-Postulat-Schmid.png https://www.interpharma.ch/fr/blog/serie-de-blogs-sur-la-conference-de-presse-annuelle-dinterpharma-partie-3-acces-des-patient-e-s-il-faut-un-equilibre-entre-la-qualite-les-couts-et-la-securite-dapprovisi/ 2026-02-26T09:32:49+00:00 https://www.interpharma.ch/wp-content/uploads/2023/01/443_Interpharma-scaled.jpg https://interpharma.ch/wp-content/uploads/2023/01/image.png https://interpharma.ch/wp-content/uploads/2023/01/image-1.png https://interpharma.ch/wp-content/uploads/2023/01/image-2.png https://interpharma.ch/wp-content/uploads/2023/01/image-3.png https://interpharma.ch/wp-content/uploads/2023/01/image-4.png https://www.interpharma.ch/fr/blog/blogserie-amr-awareness-week-2022-teil-1-neue-antibiotika-sollten-als-versicherung-fuer-kuenftige-gesundheitskrisen-angesehen-werden/ 2026-02-26T09:32:50+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/blog-image-067.jpg https://www.interpharma.ch/fr/blog/blogserie-animal-welfare-report-2022-teil-2-notwendige-tierversuche-und-die-ubertragbarkeit-der-ergebnisse-auf-den-menschen-ii/ 2026-02-26T09:32:50+00:00 https://www.interpharma.ch/wp-content/uploads/2022/11/AWR-22-Website-1.jpg https://www.interpharma.ch/fr/blog/blogserie-animal-welfare-report-2022-teil-1-notwendige-tierversuche-und-die-uebertragbarkeit-der-ergebnisse-auf-den-menschen/ 2026-02-26T09:32:50+00:00 https://www.interpharma.ch/wp-content/uploads/2022/11/AWR-22-Website-1.jpg https://www.interpharma.ch/fr/blog/communique-de-presse-un-succes-pour-la-place-suisse-et-la-securite-dapprovisionnement/ 2026-02-26T09:32:50+00:00 https://www.interpharma.ch/fr/blog/un-defi-toujours-plus-grand-lindustrie-pharmaceutique-reste-tributaire-de-conditions-cadres-attrayantes/ 2026-02-26T09:32:50+00:00 https://www.interpharma.ch/fr/blog/les-adpic-en-bref/ 2026-02-26T09:32:50+00:00 https://www.interpharma.ch/fr/blog/gute-nachrichten-fuer-den-produktionsstandort-schweiz/ 2026-02-26T09:32:50+00:00 https://www.interpharma.ch/fr/?p=12775 2026-02-26T09:32:50+00:00 https://www.interpharma.ch/fr/blog/blogserie-animal-welfare-report-2022-teil-3-auf-dem-weg-vom-zuchtbetrieb-zum-labor-steht-das-tierwohl-an-erster-stelle/ 2026-02-26T09:32:50+00:00 https://www.interpharma.ch/fr/blog/medienmitteilung-animal-welfare-report-2022-tierversuche-sind-immer-noch-unerlaesslich-fuer-die-erforschung-neuer-behandlungsansaetze/ 2026-02-26T09:32:51+00:00 https://www.interpharma.ch/wp-content/uploads/2022/11/AWR-22-Website-1.jpg https://www.interpharma.ch/fr/blog/couts-de-sante-et-prix-des-medicaments-eclaircissements/ 2026-02-26T09:32:51+00:00 https://www.interpharma.ch/wp-content/uploads/2022/10/iph_panorama22_D_S14.png https://interpharma.ch/wp-content/uploads/2022/10/iph_panorama22_D_S14-1024x683.png https://interpharma.ch/wp-content/uploads/2022/10/iph_panorama22_D_S16-1024x683.png https://interpharma.ch/wp-content/uploads/2022/10/iph_panorama22_D_S15-1-1024x683.png https://interpharma.ch/wp-content/uploads/2022/10/iph_panorama22_D_S17-1024x683.png https://interpharma.ch/wp-content/uploads/2022/10/iph_panorama22_D_S18-1024x683.png https://interpharma.ch/wp-content/uploads/2022/10/iph_panorama22_D_S19-1024x683.png https://www.interpharma.ch/fr/blog/position-commune-sur-la-revision-de-la-prise-en-charge-dans-des-cas-particuliers-oamal-art-71a-a-d/ 2026-02-26T09:32:51+00:00 https://www.interpharma.ch/wp-content/uploads/2022/10/KVV_Brief_d.png https://www.interpharma.ch/fr/blog/serie-de-blogs-sur-la-2e-volet-de-mesures-visant-a-freiner-la-hausse-des-couts-partie-3-comment-le-conseil-federal-elabore-ses-politiques-sans-tenir-compte-de-la-population/ 2026-02-26T09:32:51+00:00 https://www.interpharma.ch/wp-content/uploads/2022/10/image-3-e1665477009408.png https://interpharma.ch/wp-content/uploads/2022/10/image-3.png https://www.interpharma.ch/fr/blog/serie-de-blogs-sur-la-2e-volet-de-mesures-visant-a-freiner-la-hausse-des-couts-partie-2-un-mal-pour-un-autre/ 2026-02-26T09:32:52+00:00 https://www.interpharma.ch/wp-content/uploads/2022/10/image-3-e1665477009408.png https://interpharma.ch/wp-content/uploads/2022/10/image-1.png https://interpharma.ch/wp-content/uploads/2022/10/image-2.png https://www.interpharma.ch/fr/blog/communique-de-presse-interpharma-demande-la-creation-dun-cadre-juridique-national-sur-lutilisation-des-donnees-de-sante/ 2026-02-26T09:32:52+00:00 https://www.interpharma.ch/wp-content/uploads/2019/05/Grafik.png https://www.interpharma.ch/fr/blog/serie-de-blogs-sur-le-volet-2-1er-episode-le-secteur-pharmaceutique-soutient-les-economies-et-accepte-les-modeles-de-prix/ 2026-02-26T09:32:52+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/image-5.png https://interpharma.ch/wp-content/uploads/2022/10/image-5.png https://www.interpharma.ch/fr/blog/communique-de-presse-interpharma-rejette-categoriquement-le-projet-de-revision-de-loamal-et-de-lopas-presente-par-le-conseil-federal/ 2026-02-26T09:32:52+00:00 https://www.interpharma.ch/wp-content/uploads/2020/05/Bundeshaus-scaled.jpg https://www.interpharma.ch/fr/blog/deuxieme-volet-de-mesures-visant-a-freiner-la-hausse-des-couts-le-conseil-federal-manque-une-occasion-au-parlement-dameliorer-le-projet/ 2026-02-26T09:33:56+00:00 https://www.interpharma.ch/wp-content/uploads/2022/06/Notfall.jpg https://www.interpharma.ch/fr/blog/rapport-sur-le-remboursement-des-medicaments-pour-les-en-fants-atteints-dun-cancer-le-conseil-federal-cree-de-nouveaux-problemes/ 2026-02-26T09:33:56+00:00 https://www.interpharma.ch/wp-content/uploads/2021/02/iStock-1064859060-scaled.jpg https://www.interpharma.ch/fr/blog/panorama-de-la-sante-une-contribution-importante-au-dialogue-sur-les-soins-de-sante-et-la-place-pharmaceutique/ 2026-02-26T09:33:56+00:00 https://www.interpharma.ch/wp-content/uploads/2022/09/thmb-Panorama.png https://interpharma.ch/wp-content/uploads/2022/08/Bullets_Panorama-1024x873.png https://www.interpharma.ch/fr/blog/ecosysteme-de-donnees-de-sante-le-rapport-esquisse-des-pistes/ 2026-02-26T09:33:58+00:00 https://www.interpharma.ch/wp-content/uploads/2020/09/Digitalisierung-allgemein-scaled.jpg https://www.interpharma.ch/fr/blog/serie-de-blogs-qui-finance-les-medicaments-partie-1-vaccins-contre-le-covid-19-un-succes-qui-a-son-revers/ 2026-02-26T09:33:58+00:00 https://www.interpharma.ch/wp-content/uploads/2022/07/Bild1_2-1.png https://www.interpharma.ch/wp-content/uploads/2026/02/fabrik.svg https://www.interpharma.ch/wp-content/uploads/2026/02/kasse.svg https://www.interpharma.ch/wp-content/uploads/2026/02/luftverkehr.svg https://www.interpharma.ch/wp-content/uploads/2026/02/strom.svg https://www.interpharma.ch/fr/blog/medienmitteilung-massnahmen-des-masterplans-2022-2026-zur-staerkung-der-biomedizinischen-forschung-und-technologie-in-der-schweiz-verpasste-chance/ 2026-02-26T09:33:59+00:00 https://www.interpharma.ch/wp-content/uploads/2022/03/iStock-1293772969.jpg https://www.interpharma.ch/fr/blog/un-signal-desastreux-en-prevision-dune-prochaine-pandemie/ 2026-02-26T09:33:59+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/blog-image-073-scaled.jpg https://www.interpharma.ch/fr/blog/medienmitteilung-gesundheitsmonitor-2022-die-pandemie-bestaetigt-die-notwendigkeit-eines-schnellen-zugangs-zu-neuen-medikamenten/ 2026-02-26T09:33:59+00:00 https://www.interpharma.ch/wp-content/uploads/2022/06/Gesundheitsmonitor-Web-D.png https://www.interpharma.ch/fr/blog/eine-schwaechung-des-patentschutzes-waere-gefaehrlich-und-kontraproduktiv/ 2026-02-26T09:33:59+00:00 https://www.interpharma.ch/wp-content/uploads/2021/10/IP-scaled.jpg https://www.interpharma.ch/fr/blog/la-protection-de-la-propriete-intellectuelle-nest-pas-le-probleme-mais-plutot-la-solution-interview-avec-rene-buholzer-en-agefi/ 2026-02-26T09:34:00+00:00 https://www.interpharma.ch/wp-content/uploads/2021/10/IP-scaled.jpg https://www.interpharma.ch/fr/blog/la-revision-de-loamal-aggrave-encore-le-probleme-dacces-des-patientes-et-patients/ 2026-02-26T09:34:00+00:00 https://www.interpharma.ch/wp-content/uploads/2022/06/Notfall.jpg https://www.interpharma.ch/fr/blog/medienmitteilung-auslandpreisvergleich-medikamente-preisdifferenz-zum-ausland-nimmt-zu-markante-preisunterscheide-auch-bei-generika-und-biosimilars/ 2026-02-26T09:34:00+00:00 https://www.interpharma.ch/wp-content/uploads/2022/05/APV-22-D1.png https://www.interpharma.ch/fr/blog/serie-acces-des-patients-partie-3-reponses-aux-questions-et-critiques/ 2026-02-26T09:34:01+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/blog-image-091-scaled.png https://www.interpharma.ch/fr/blog/medienmitteilung-interpharma-schlaegt-einen-rueckvergueteten-innovationszugang-fuer-patientinnen-und-patienten-vor/ 2026-02-26T09:34:01+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/blog-image-083-scaled.png https://www.interpharma.ch/wp-content/uploads/2026/02/Element-1.svg https://www.interpharma.ch/fr/blog/serie-acces-des-patients-partie-2-remboursement-de-lacces-a-linnovation-pour-assurer-que-tous-les-patients-et-patientes-en-beneficient-equitablement-et-rapidement/ 2026-02-26T09:34:01+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/blog-image-089-scaled.png https://www.interpharma.ch/fr/blog/serie-acces-des-patients-partie-1-en-suisse-lacces-des-patient-e-s-a-linnovation-est-fortement-retarde/ 2026-02-26T09:34:02+00:00 https://www.interpharma.ch/wp-content/uploads/2022/04/patient-access-gap.png https://www.interpharma.ch/wp-content/uploads/2026/02/intergenerika-removebg-preview.png https://www.interpharma.ch/fr/blog/medienmitteilung-fuehrend-in-der-entwicklung-von-mrna-medikamenten-moderna-wird-mitglied-bei-interpharma/ 2026-02-26T09:34:02+00:00 https://www.interpharma.ch/wp-content/uploads/2022/04/Annual-Conference-2022.jpeg https://www.interpharma.ch/fr/blog/medienmitteilung-schweizer-bevoelkerung-erachtet-schutz-des-geistigen-eigentums-als-grundlegend-fuer-die-innovation/ 2026-02-26T09:34:02+00:00 https://www.interpharma.ch/wp-content/uploads/2022/03/iStock-1293772969.jpg https://www.interpharma.ch/fr/blog/medienmitteilung-europabefragung-2022-die-schweizer-bevoelkerung-zeigt-sich-offen-fuer-einen-kompromiss/ 2026-02-26T09:34:03+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/bild_schweiz-EU_kachel_380x150.jpg https://www.interpharma.ch/fr/blog/pharmaindustrie-zeigt-sich-solidarisch-mit-der-bevoelkerung-in-der-ukraine/ 2026-02-26T09:34:03+00:00 https://www.interpharma.ch/wp-content/uploads/2022/03/Flage-Ukraine-scaled.jpg https://www.interpharma.ch/fr/blog/medienmitteilung-ein-starkes-bekenntnis-zum-forschungsstandort-schweiz/ 2026-02-26T09:34:04+00:00 https://www.interpharma.ch/wp-content/uploads/2020/05/Bundeshaus-scaled.jpg https://www.interpharma.ch/fr/blog/medienmitteilung-wachstum-des-medikamentenmarktes-wird-durch-preissenkungen-gedaempft/ 2026-02-26T09:34:04+00:00 https://www.interpharma.ch/fr/blog/medienmitteilung-forschende-pharmaindustrie-sieht-wachsende-herausforderungen-fuer-den-standort-schweiz/ 2026-02-26T09:34:04+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/blog-image-049.jpg https://www.interpharma.ch/fr/blog/medienmitteilung-nein-zur-forschungsverbotsinitiative-interpharma-lanciert-kampagne-gegen-die-extreme-tier-und-menschenversuchsverbotsinitiative/ 2026-02-26T09:34:05+00:00 https://www.interpharma.ch/wp-content/uploads/2021/12/1117001.png https://www.interpharma.ch/fr/blog/3-fragen-an-joerg-storre-geschaeftsfuehrer-general-manager-von-vifor-pharma-schweiz/ 2026-02-26T09:34:05+00:00 https://www.interpharma.ch/wp-content/uploads/2021/12/Joerg-Storre.jpg https://www.interpharma.ch/fr/blog/la-fiabilite-de-la-suisse-en-tant-que-partenaire-contractuelle-imprudemment-compromise/ 2026-02-26T09:34:52+00:00 https://www.interpharma.ch/wp-content/uploads/2021/12/Impfstoff-Vertr%C3%A4ge.jpg https://www.interpharma.ch/fr/blog/medienmitteilung-bak-studie-zeigt-herausragende-bedeutung-der-pharmaindustrie-fuer-die-schweiz-interpharma-fordert-strategie-zur-langfristigen-sicherung-des-pharmastandortes-schweiz/ 2026-02-26T09:34:52+00:00 https://www.interpharma.ch/wp-content/uploads/2021/11/Bedeutungsstudie-21-WEB.png https://www.interpharma.ch/fr/blog/medienmitteilung-animal-welfare-report-2021-kontrolle-statt-verbote/ 2026-02-26T09:34:53+00:00 https://www.interpharma.ch/wp-content/uploads/2021/11/Titelbild-AWR-Web.png https://www.interpharma.ch/fr/blog/la-recherche-continue-interpharma-lance-une-campagne-de-sensibilisation/ 2026-02-26T09:34:53+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/blog-image-003.jpg https://www.interpharma.ch/fr/blog/oui-a-la-protection-de-nos-employes-oui-a-la-loi-covid-19/ 2026-02-26T09:34:54+00:00 https://www.interpharma.ch/wp-content/uploads/2020/05/Bundeshaus-scaled.jpg https://www.interpharma.ch/fr/blog/medienmitteilung-sechs-handlungsfelder-als-grundlage-fuer-eine-kohaerente-digita-lisierungsstrategie-im-gesundheitswesen/ 2026-02-26T09:34:54+00:00 https://www.interpharma.ch/wp-content/uploads/2021/06/Erkenntnisse-aus-der-Krise.png https://www.interpharma.ch/fr/blog/pour-un-dialogue-sur-le-systeme-de-sante-et-le-pole-pharmaceutique-suisse-base-sur-les-faits/ 2026-02-26T09:34:54+00:00 https://www.interpharma.ch/wp-content/uploads/2022/09/thmb-Panorama.png https://www.interpharma.ch/fr/blog/medienmitteilung-fuenf-erkenntnisse-aus-der-krise-fuer-die-zukunft-des-schweizer-gesundheitswesens/ 2026-02-26T09:34:54+00:00 https://www.interpharma.ch/wp-content/uploads/2021/06/Erkenntnisse-aus-der-Krise.png https://www.interpharma.ch/fr/blog/update-projekte-und-massnahmen-forschender-pharma-unternehmen-gegen-die-coronavirus-epidemie-covid-19-2/ 2026-02-26T09:34:54+00:00 https://www.interpharma.ch/wp-content/uploads/2020/03/Corona-scaled.jpg https://www.interpharma.ch/wp-content/uploads/2020/04/2020-03-24_IntPh-JB2019_EN-1-pdf.jpg https://www.interpharma.ch/fr/blog/medienmitteilung-gesundheitsmonitor-2021-covid-19-luecken-des-gesundheitssystems-werden-sichtbar-wichtige-rolle-der-pharmaindustrie-anerkannt/ 2026-02-26T09:34:55+00:00 https://www.interpharma.ch/wp-content/uploads/2021/06/Gesundheitsmonitor.png https://www.interpharma.ch/fr/blog/medienmitteilung-auslandpreisvergleich-medikamente-wechselkurse-erhoehen-die-preisunterschiede-im-vergleich-zum-ausland-generika-medikamente-werden-teurer/ 2026-02-26T09:34:55+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/blog-image-024-scaled.jpeg https://www.interpharma.ch/fr/blog/medienmitteilung-schweiz-eu-forschende-pharmaindustrie-in-der-schweiz-fordert-den-bundesrat-auf-jetzt-schnellstmoeglich-zu-handeln-und-alternativen-zu-entwickeln/ 2026-02-26T09:34:55+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/bild_schweiz-EU_kachel_380x150.jpg https://www.interpharma.ch/fr/blog/medienmitteilung-trotz-unklarem-kontext-unterstuetzen-64-der-stimmbevoelkerung-weiterhin-das-rahmenabkommen-mit-der-eu/ 2026-02-26T09:34:56+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/bild_schweiz-EU_kachel_380x150.jpg https://www.interpharma.ch/fr/blog/medienmitteilung-ein-aussetzen-der-patentrechte-ist-keine-loesung/ 2026-02-26T09:34:56+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/blog-image-074-scaled.jpg https://www.interpharma.ch/fr/blog/schweiz-eu-forschende-pharmaindustrie-in-der-schweiz-fordert-den-bundesrat-auf-schnellstmoeglich-zu-handeln/ 2026-02-26T09:34:57+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/bild_schweiz-EU_kachel_380x150.jpg https://www.interpharma.ch/fr/blog/neue-informationsuebersicht-zu-neuigkeiten-der-forschenden-pharmaindustrie-und-datenzusammenstellungen-auf-einen-blick/ 2026-02-26T09:34:57+00:00 https://www.interpharma.ch/wp-content/uploads/2020/09/Digitalisierung-allgemein-scaled.jpg https://www.interpharma.ch/fr/blog/grosse-molekuele-grosse-wirkung-was-sind-biopharmazeutika/ 2026-02-26T09:34:58+00:00 https://www.interpharma.ch/wp-content/uploads/2021/04/ASS-vs.-IgG-Antik%C3%B6rper.jpg https://www.interpharma.ch/wp-content/uploads/2025/04/Bild-franzoesisch.png https://www.interpharma.ch/fr/blog/medienmitteilung-interpharma-blickt-auf-das-pandemiejahr-2020-zurueck/ 2026-02-26T09:34:58+00:00 https://www.interpharma.ch/wp-content/uploads/2021/03/Jahresbericht-2020-Titelbild.png https://www.interpharma.ch/fr/blog/serie-animal-welfare-teil-2-massstaebe-setzen-zehn-jahre-animal-welfare-charta/ 2026-02-26T09:35:16+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/blog-image-073-scaled.jpg https://www.interpharma.ch/fr/blog/die-herstellung-von-impfstoffen-ein-komplexer-prozess/ 2026-02-26T09:35:16+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/blog-image-074-scaled.jpg https://www.interpharma.ch/fr/blog/ein-starker-pharmastandort-ist-die-beste-krisenvorsorge-2/ 2026-02-26T09:35:16+00:00 https://www.interpharma.ch/wp-content/uploads/2020/02/VD19842-scaled.jpg https://www.interpharma.ch/fr/blog/gemeinsam-gegen-covid-19-ohne-tierversuche-wird-es-weder-impfstoffe-noch-therapien-gegen-covid-19-geben/ 2026-02-26T09:35:16+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/blog-image-073-scaled.jpg https://www.interpharma.ch/fr/blog/die-verschiedenen-arten-von-impfstoffen-kurz-erklaert/ 2026-02-26T09:35:16+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/blog-image-062.jpg https://www.interpharma.ch/wp-content/uploads/2024/03/pdf24_zusammengefuegt.pdf https://www.interpharma.ch/fr/blog/medienmitteilung-forschende-pharmaindustrie-zieht-bilanz-ein-innovativer-pharmastandort-ist-die-beste-krisenvorsorge/ 2026-02-26T09:35:17+00:00 https://www.interpharma.ch/wp-content/uploads/2020/09/Digitalisierung-allgemein-scaled.jpg https://www.interpharma.ch/fr/blog/medikamentenmarkt-waechst-leicht-um-2-9/ 2026-02-26T09:35:17+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/blog-image-024-scaled.jpeg https://www.interpharma.ch/fr/blog/ein-starker-pharmastandort-ist-die-beste-krisenvorsorge/ 2026-02-26T09:35:17+00:00 https://www.interpharma.ch/wp-content/uploads/2020/02/VD19842-scaled.jpg https://www.interpharma.ch/fr/blog/medienmitteilung-massstaebe-setzen-zehn-jahre-animal-welfare-charta/ 2026-02-26T09:35:18+00:00 https://www.interpharma.ch/wp-content/uploads/2020/12/Animal-Welfare-Report-2020.png https://www.interpharma.ch/fr/blog/communique-de-presse-mesures-visant-a-freiner-la-hausse-des-couts-volet-2-les-modeles-de-prix-doivent-accelerer-lacces-des-patient-e-s-a-linnovation/ 2026-02-26T09:35:18+00:00 https://www.interpharma.ch/wp-content/uploads/2020/05/Bundeshaus-scaled.jpg https://www.interpharma.ch/fr/blog/le-rejet-de-linitiative-contre-les-bilaterales-est-rejouissant-il-faut-maintenant-faire-evoluer-les-relations-bilaterales/ 2026-02-26T09:35:19+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/bild_schweiz-EU_kachel_380x150.jpg https://www.interpharma.ch/fr/blog/notre-engagement-dans-cette-situation-particuliere-5-5-place-de-production-pharmaceutique/ 2026-02-26T09:35:20+00:00 https://www.interpharma.ch/wp-content/uploads/2020/07/Interpharma_Titelbild_Home_Icon_05.jpg https://www.interpharma.ch/wp-content/uploads/2020/11/Animal-Welfare-Report-2021-EN1.pdf https://www.interpharma.ch/fr/blog/notre-engagement-dans-cette-situation-particuliere-4-5-recherche-et-innovation/ 2026-02-26T09:35:20+00:00 https://www.interpharma.ch/wp-content/uploads/2020/07/Interpharma_Titelbild_Home_Icon_04-1.jpg https://www.interpharma.ch/wp-content/uploads/2020/09/Alzheimer-2.png https://www.interpharma.ch/fr/blog/notre-engagement-dans-cette-situation-particuliere-3-5-coopereation/ 2026-02-26T09:35:21+00:00 https://www.interpharma.ch/wp-content/uploads/2020/07/Interpharma_Titelbild_Home_Icon_03.jpg https://www.interpharma.ch/wp-content/uploads/2020/08/Panorama-de-la-Sant%C3%A9.png https://www.interpharma.ch/fr/blog/unser-engagement-in-der-besonderen-lage-2-5-versorgungssicherheit/ 2026-02-26T09:35:21+00:00 https://www.interpharma.ch/wp-content/uploads/2020/07/Interpharma_Titelbild_Home_Icon_02.jpg https://www.interpharma.ch/wp-content/uploads/2020/08/20200730_Ex-Sum-Bench-2020_final_DFE.pdf https://www.interpharma.ch/fr/blog/nouveaux-faits-et-chiffres-sur-le-systeme-de-sante-et-le-paysage-pharmaceutique-suisses/ 2026-02-26T09:35:21+00:00 https://www.interpharma.ch/wp-content/uploads/2022/09/thmb-Panorama.png https://www.interpharma.ch/fr/blog/auslandpreisvergleich-medikamente-preisdifferenz-zum-ausland-bei-patentgeschuetzten-medikamenten-sinkt-weiter/ 2026-02-26T09:35:22+00:00 https://www.interpharma.ch/wp-content/uploads/2020/08/APV-Bild-1.png https://www.interpharma.ch/wp-content/uploads/2020/02/gesundheitswesen_schweiz_2019_f-komprimiert-pdf-1.jpg https://www.interpharma.ch/wp-content/uploads/2020/02/grafik_gesundheitswesen.png https://www.interpharma.ch/fr/blog/auslandpreisvergleich-medikamente-preisdifferenz-zum-ausland-sinkt-bei-patentgeschuetzten-medikamenten-weiter-nach-wie-vor-grosser-preisunterschied-bei-generika/ 2026-02-26T09:35:22+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/bild_schweiz-EU_kachel_380x150.jpg https://www.interpharma.ch/fr/blog/unser-engagement-in-der-besonderen-lage-diagnostika-medikamente-impfstoffe/ 2026-02-26T09:35:22+00:00 https://www.interpharma.ch/wp-content/uploads/2020/07/Interpharma_Titelbild_Home_Icon_01.jpg https://www.interpharma.ch/wp-content/uploads/2020/11/Titelbild-AWR-2021-F.png https://www.interpharma.ch/fr/blog/communique-de-presse-le-conseil-des-etats-risque-une-crise-dapprovisionnement-en-medicaments/ 2026-02-26T15:15:01+00:00 https://www.interpharma.ch/wp-content/uploads/2023/09/KP2_klein.png https://www.interpharma.ch/fr/blog/acces-aux-nouveaux-medicaments-un-defia-portee-de-main/ 2026-02-26T15:20:51+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/width1920quality75formatauto.avif https://www.interpharma.ch/fr/blog/sustainable-development-goals-bayer-entwickelt-gemeinsam-mit-schweizer-institut-tph-behandlung-gegen-wurmerkrankungen-im-menschen/ 2026-02-27T10:12:50+00:00 https://www.interpharma.ch/wp-content/uploads/2023/11/female_doctor_examining_african_child-scaled.jpeg https://interpharma.ch/wp-content/uploads/2023/11/doctor_examining_african_girl-1-1024x683.jpeg https://www.interpharma.ch/fr/blog/johnson-johnson-sustainable-today-healthy-tomorrow/ 2026-02-27T10:17:35+00:00 https://www.interpharma.ch/wp-content/uploads/2023/02/janssen-SDG-2023-scaled.jpg https://www.interpharma.ch/fr/blog/serie-sustainable-development-goals-johnson-johnson-engagiert-sich-fuer-klimaschutz-mit-konkreten-projekten/ 2026-02-27T10:23:03+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/blog-image-076-scaled.jpg https://www.interpharma.ch/fr/blog/sustainable-development-goals-bayer-entwickelt-gemeinsam-mit-schweizer-institut-tph-behandlung-gegen-wurmerkrankungen-im-menschen/ 2026-02-27T10:26:07+00:00 https://www.interpharma.ch/wp-content/uploads/2023/11/female_doctor_examining_african_child-scaled.jpeg https://interpharma.ch/wp-content/uploads/2023/11/doctor_examining_african_girl-2-1024x683.jpeg https://www.interpharma.ch/fr/blog/sustainable-development-goals-bayer-entwickelt-gemeinsam-mit-schweizer-institut-tph-behandlung-gegen-wurmerkrankungen-im-menschen/ 2026-02-27T10:27:00+00:00 https://www.interpharma.ch/wp-content/uploads/2023/11/female_doctor_examining_african_child-scaled.jpeg https://interpharma.ch/wp-content/uploads/2023/11/doctor_examining_african_girl-1024x683.jpeg https://www.interpharma.ch/fr/blog/3-questions-a-nos-nouveaux-vice-chair-du-comite-place-suisse-bairbre-hickie-general-manager-suisse-takeda/ 2026-03-03T08:36:13+00:00 https://www.interpharma.ch/wp-content/uploads/2026/01/BAIRBRE_HICKIE_DSC8736-1-scaled.jpg https://interpharma.ch/wp-content/uploads/2026/01/BAIRBRE_HICKIE_DSC8736-2-1024x768.jpg https://www.interpharma.ch/fr/blog/3-questions-a-la-nouvelle-responsable-du-comite-marche-myriam-deleone-directrice-generale-damgen-suisse/ 2026-03-03T08:36:48+00:00 https://www.interpharma.ch/wp-content/uploads/add-from-server-reloaded/L1040074-2-Bearbeitet-scaled-e1765550553239.jpg https://interpharma.ch/wp-content/uploads/2025/12/L1040074-2-Bearbeitet-683x1024.jpg https://www.interpharma.ch/fr/blog/amr-awareness-week-2025-partie-2-lavancee-insidieuse-de-lantibioresistance/ 2026-03-03T08:37:25+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/blog-image-052.png https://www.interpharma.ch/fr/blog/communique-de-presse-bilaterales-iii-relations-stables-avec-le-principal-partenaire-commercial/ 2026-03-03T08:39:33+00:00 https://www.interpharma.ch/wp-content/uploads/2024/03/CH_EU_generisch-klein-scaled.jpg https://www.interpharma.ch/fr/blog/communique-de-presse-lindustrie-pratiquant-la-recherche-prend-note-de-la-conclusion-de-laccord-de-libre-echange-avec-le-mercosur/ 2026-03-03T08:39:47+00:00 https://www.interpharma.ch/wp-content/uploads/2025/07/EFTA-Mercosur.jpg https://interpharma.ch/wp-content/uploads/2025/07/image-1.png https://www.interpharma.ch/fr/blog/communique-de-presse-acces-aux-nouveaux-medicaments-la-suisse-continue-de-perdre-du-terrain-la-prise-en-charge-des-patient-e-s-et-la-place-suisse-sont-en-danger/ 2026-03-03T08:40:03+00:00 https://www.interpharma.ch/wp-content/uploads/2021/02/iStock-1064859060-scaled.jpg https://www.interpharma.ch/fr/blog/3-questions-a-nos-nouveaux-membres-du-conseil-dadministration-iris-zemzoum-president-region-europe-chez-novartis-et-vice-president-du-conseil-dadministration/ 2026-03-03T08:40:33+00:00 https://www.interpharma.ch/wp-content/uploads/2025/06/Beitragsbild_3-Fragen-an-Iris-Zemzoum.png https://interpharma.ch/wp-content/uploads/2025/06/Photo-Iris-Zemzoum-1.jpg https://www.interpharma.ch/fr/blog/3-fragen-an-unsere-neuen-boardmitglieder-florian-saur-country-general-manager-switzerland-astrazeneca/ 2026-03-03T08:40:50+00:00 https://www.interpharma.ch/wp-content/uploads/2025/06/AZ_Florian-Saur_1-scaled.jpg https://interpharma.ch/wp-content/uploads/2025/06/AZ_Florian-Saur_1-1024x683.jpg https://www.interpharma.ch/fr/blog/3-questions-a-nos-nouveaux-membres-du-conseil-dadministration-linn-mandahl-vice-president-europe-region-south-chez-abbvie/ 2026-03-03T08:41:40+00:00 https://www.interpharma.ch/wp-content/uploads/2025/05/Beitragsbild-3-Fragen-an-Linn-Mandahl-1.png https://interpharma.ch/wp-content/uploads/2025/05/Linn-Mandahl-2-683x1024.jpg https://www.interpharma.ch/fr/blog/3-questions-a-nos-nouveaux-membres-du-comite-david-traub-directeur-de-novartis-pharma-schweiz-ag/ 2026-03-03T08:41:56+00:00 https://www.interpharma.ch/wp-content/uploads/2025/05/Beitragsbild-3-Fragen-an-David-Traub-1.png https://interpharma.ch/wp-content/uploads/2025/05/David-Traub-2-748x1024.jpg https://www.interpharma.ch/fr/blog/la-prevention-dans-le-systeme-de-sante-suisse/ 2026-03-03T08:42:51+00:00 https://www.interpharma.ch/wp-content/uploads/2025/04/Bildschirmfoto-2022-03-21-um-11.51.57-1.jpg https://interpharma.ch/wp-content/uploads/2025/04/Bildschirmfoto-2022-03-21-um-11.51.57-3-1024x594.jpg https://www.interpharma.ch/fr/blog/acces-a-linnovation-dans-les-domaines-de-la-prevention-et-du-depistage-precoce/ 2026-03-03T08:43:07+00:00 https://www.interpharma.ch/wp-content/uploads/2025/04/iStock_Herz_Praevention.jpg https://www.interpharma.ch/fr/blog/lutilisation-des-donnees-comme-cle-dune-prevention-plus-ciblee/ 2026-03-03T08:43:20+00:00 https://www.interpharma.ch/wp-content/uploads/2025/04/NF_AI4HealthyCities_Skyline_Banner-scaled.jpg https://www.interpharma.ch/fr/blog/strategie-et-coordination-globales/ 2026-03-03T08:43:32+00:00 https://www.interpharma.ch/wp-content/uploads/2025/04/Bild_Blogbeitrag-2.png https://www.interpharma.ch/fr/blog/une-prevention-ciblee-et-une-detection-precoce-comme-cles-de-la-reussite-a-long-terme/ 2026-03-03T08:43:53+00:00 https://www.interpharma.ch/wp-content/uploads/2025/04/Beitragsbild-englisch-1.png https://www.interpharma.ch/fr/blog/la-prevention-comme-element-dun-systeme-de-sante-suisse-perenne/ 2026-03-03T08:44:05+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/blog-image-080-scaled.png https://www.interpharma.ch/fr/blog/journee-de-lindustrie-pharmaceutique-2025-renforcer-la-competitivite-de-lindustrie-pharmaceutique-suisse/ 2026-03-03T08:44:22+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/bild_schweiz-EU_kachel_380x150.jpg https://www.interpharma.ch/fr/blog/medienmitteilung-daiichi-sankyo-wird-mitglied-bei-interpharma/ 2026-03-03T08:44:33+00:00 https://www.interpharma.ch/wp-content/uploads/2025/04/Ausschnitt-Jahresbericht-2024.jpg https://www.interpharma.ch/fr/blog/lung-on-chip-eine-humane-loesung-zur-pruefung-von-lungenfunktion-und-toxizitaet/ 2026-03-03T08:45:12+00:00 https://www.interpharma.ch/wp-content/uploads/2025/01/2021-3RCC-026-scaled.jpg https://www.interpharma.ch/fr/blog/blogserie-mit-dem-3rcc-teil-9-neue-therapien-im-fokus-wie-bahnbrechende-tierversuchsfreie-forschung-den-weg-zur-behandlung-der-fettleber-ebnet/ 2026-03-03T08:45:24+00:00 https://www.interpharma.ch/wp-content/uploads/2024/11/BIld-Artikel-9-Liver_organoid-scaled.jpg https://www.interpharma.ch/fr/blog/blogserie-mit-dem-3rcc-teil-8-koennen-insekten-emotionen-empfinden-neue-studien-entfachen-eine-debatte-ueber-die-schmerzempfindlichkeit-wirbelloser-lebewesen/ 2026-03-03T08:45:41+00:00 https://www.interpharma.ch/wp-content/uploads/2024/10/Artikel-8-AdobeStock_741829926-scaled.jpeg https://www.interpharma.ch/fr/blog/blogserie-mit-dem-3rcc-teil-7-neue-methode-simuliert-echte-gewebestrukturen-ein-grosser-schritt-fuer-die-zukunft-der-krebsforschung/ 2026-03-03T08:45:51+00:00 https://www.interpharma.ch/wp-content/uploads/2024/10/Artikel-7-pdac_ck7_dapi_day13.png https://www.interpharma.ch/fr/blog/blogserie-mit-dem-3rcc-teil-6-wachstumswunder-wie-radial-verteilte-stammzellen-das-wachstum-von-organoiden-foerdern/ 2026-03-03T08:46:01+00:00 https://www.interpharma.ch/wp-content/uploads/2024/09/Bild-Artikel-6-OCTOPUS-THUMBNAIL.png https://www.interpharma.ch/fr/blog/sommerblogserie-mit-dem-3rcc-teil-5-3d-gedrucktes-modell-revolutioniert-die-krebsforschung/ 2026-03-03T08:46:12+00:00 https://www.interpharma.ch/wp-content/uploads/2024/09/iStock-1530776415.jpg https://www.interpharma.ch/fr/blog/hightech-pharmaproduktion-in-der-schweizer-pharmaindustrie-innovation-und-effizienz/ 2026-03-03T08:46:27+00:00 https://www.interpharma.ch/wp-content/uploads/2024/09/Anzeigebild-EN.jpg https://www.interpharma.ch/fr/blog/naeher-an-der-loesung-des-praeeklampsie-raetsels-in-vitro-trophoblastzellen-in-aktion/ 2026-03-03T08:46:39+00:00 https://www.interpharma.ch/wp-content/uploads/2024/09/2023-Swiss3RCC-003-low.jpg https://www.interpharma.ch/fr/blog/communique-de-presse-panorama-de-la-sante-2024-contribution-factuelle-au-dialogue-en-faveur-dun-systeme-de-sante-davenir/ 2026-03-03T08:46:51+00:00 https://www.interpharma.ch/wp-content/uploads/2024/08/Front-EN.png https://interpharma.ch/wp-content/uploads/2024/08/Key-facts-1-1024x669.png https://www.interpharma.ch/fr/blog/medienmitteilung-europabefragung-2024-die-schweizer-stimmbevoelkerung-steht-klar-hinter-den-bilateralen-und-zeigt-sich-kompromissbereit/ 2026-03-03T08:47:01+00:00 https://www.interpharma.ch/wp-content/uploads/2024/03/CH_EU_generisch-klein-scaled.jpg https://www.interpharma.ch/fr/blog/sommerblogserie-zusammen-mit-dem-3rcc-teil-3-das-gehirn-und-die-zeit-was-fruchtfliegen-uns-verraten/ 2026-03-03T08:47:19+00:00 https://www.interpharma.ch/wp-content/uploads/2024/08/FlyCircadianRhythm.png https://interpharma.ch/wp-content/uploads/2024/08/FlyCircadianRhythm.png https://www.interpharma.ch/fr/blog/sommerblogserie-zusammen-mit-dem-3rcc-teil-2-erforschung-von-blutstammzellen-erkenntnisse-aus-bildgebenden-verfahren-ueber-die-entwicklung-von-zebrafischen/ 2026-03-03T08:47:30+00:00 https://www.interpharma.ch/wp-content/uploads/2024/07/Zebrafisch.png https://www.interpharma.ch/fr/blog/sommerblogserie-zusammen-mit-dem-3rcc-teil-1-wie-darmbakterien-das-sozialverhalten-von-zebrafischen-beeinflussen/ 2026-03-03T08:47:41+00:00 https://www.interpharma.ch/wp-content/uploads/2024/07/Zebrafisch.png https://interpharma.ch/wp-content/uploads/2024/07/Zebrafisch.png https://www.interpharma.ch/fr/blog/3-fragen-an-unsere-neuen-boardmitglieder-florian-schick-president-merck-switzerland/ 2026-03-03T08:47:51+00:00 https://www.interpharma.ch/wp-content/uploads/2024/07/Schick_1_klein.jpg https://interpharma.ch/wp-content/uploads/2024/07/Schick_1.jpg https://www.interpharma.ch/fr/blog/communique-de-presse-animal-welfare-report-2023-utiliser-la-transformation-numerique-de-la-recherche-sur-les-animaux-pour-faire-avancer-les-principes-des-3r/ 2026-03-03T08:48:49+00:00 https://www.interpharma.ch/wp-content/uploads/2023/11/Animal-Welfare-1.jpg https://www.interpharma.ch/fr/blog/panorama-de-la-sante-2023-puissions-nous-connaitre-90-annees-supplementaires-dinnovation-et-de-qualite-dans-le-domaine-de-la-sante/ 2026-03-03T08:49:05+00:00 https://www.interpharma.ch/wp-content/uploads/2023/08/Cover_EN.png https://interpharma.ch/wp-content/uploads/2023/08/Bullets-EN.png https://www.interpharma.ch/fr/blog/internationaler-tag-der-klinischen-forschung-3-fragen-an-prof-dr-med-miklos-pless-praesident-sakk/ 2026-03-03T08:49:17+00:00 https://www.interpharma.ch/wp-content/uploads/2023/05/Pless-Miklos.jpg https://www.interpharma.ch/fr/blog/3-fragen-an-thorsten-hein-mitglied-interpharma-board-und-country-division-head-pharmaceuticals-bayer-schweiz/ 2026-03-03T08:49:28+00:00 https://www.interpharma.ch/wp-content/uploads/2021/11/ThorstenHein.neu_.png https://www.interpharma.ch/fr/blog/3-fragen-an-graham-dorey-mitglied-interpharma-board-und-general-manager-schweiz-biogen/ 2026-03-03T08:49:39+00:00 https://www.interpharma.ch/wp-content/uploads/2023/05/dorey_741_highres-1-scaled.jpg https://www.interpharma.ch/fr/blog/3-fragen-an-max-pahlow-mitglied-interpharma-board-und-managing-director-janssen-switzerland/ 2026-03-03T08:49:49+00:00 https://www.interpharma.ch/wp-content/uploads/2023/04/klein_MAX-PAHLOW18753.jpg https://www.interpharma.ch/fr/blog/medienmitteilung-ueberarbeitung-der-allgemeinen-eu-arzneimittelvorschriften-schwerwiegende-konsequenzen-fuer-die-schweiz-erwartet/ 2026-03-03T08:50:00+00:00 https://www.interpharma.ch/wp-content/uploads/2023/04/CH_EU_generisch-scaled.jpg https://www.interpharma.ch/fr/blog/3-fragen-an-pierre-morneau-general-manager-takeda-schweiz-takeda-pharma-ag-vice-chair-innovation-hub-committee/ 2026-03-03T08:50:11+00:00 https://www.interpharma.ch/wp-content/uploads/2023/04/896_Interpharma-scaled.jpg https://www.interpharma.ch/fr/blog/communique-de-presse-interpharma-90-ans-dinnovation-et-dengagement-au-service-des-patientes-et-patients-de-suisse/ 2026-03-03T08:50:50+00:00 https://www.interpharma.ch/wp-content/uploads/2023/03/Logo_90-Jahre.jpg https://www.interpharma.ch/fr/blog/medienmitteilung-generalversammlung-von-interpharma/ 2026-03-03T08:51:00+00:00 https://www.interpharma.ch/wp-content/uploads/2023/03/Jahresbericht-2022-Titelbild-D.jpg https://www.interpharma.ch/fr/blog/medienmitteilung-europabefragung-2023-schweizer-bevoelkerung-unterstuetzt-bilaterale-noch-staerker-und-erwartet-vom-bundesrat-einen-konkreten-vorschlag/ 2026-03-03T08:51:12+00:00 https://www.interpharma.ch/wp-content/uploads/2023/03/Europabefragung-2023.jpg https://www.interpharma.ch/fr/blog/communique-de-presse-un-succes-pour-la-place-suisse-et-la-securite-dapprovisionnement/ 2026-03-03T08:51:33+00:00 https://www.interpharma.ch/wp-content/uploads/2022/12/CH-USA-scaled.jpg https://www.interpharma.ch/fr/blog/les-adpic-en-bref/ 2026-03-03T08:51:44+00:00 https://www.interpharma.ch/wp-content/uploads/2021/10/IP-scaled.jpg https://www.interpharma.ch/fr/blog/gute-nachrichten-fuer-den-produktionsstandort-schweiz/ 2026-03-03T08:52:01+00:00 https://www.interpharma.ch/wp-content/uploads/2022/12/CH-USA-scaled.jpg https://www.interpharma.ch/fr/blog/blogserie-animal-welfare-report-2022-teil-3-auf-dem-weg-vom-zuchtbetrieb-zum-labor-steht-das-tierwohl-an-erster-stelle/ 2026-03-03T08:52:37+00:00 https://www.interpharma.ch/wp-content/uploads/2022/11/AWR-22-Website-1.jpg https://www.interpharma.ch/fr/blog/blogserie-animal-welfare-report-2022-teil-2-notwendige-tierversuche-und-die-ubertragbarkeit-der-ergebnisse-auf-den-menschen-ii/ 2026-03-03T08:53:06+00:00 https://www.interpharma.ch/wp-content/uploads/2022/11/AWR-22-Website-1.jpg https://www.interpharma.ch/fr/blog/blogserie-animal-welfare-report-2022-teil-1-notwendige-tierversuche-und-die-uebertragbarkeit-der-ergebnisse-auf-den-menschen/ 2026-03-03T08:53:18+00:00 https://www.interpharma.ch/wp-content/uploads/2022/11/AWR-22-Website-1.jpg https://www.interpharma.ch/fr/blog/unser-engagement-in-der-besonderen-lage-diagnostika-medikamente-impfstoffe/ 2026-03-03T08:59:23+00:00 https://www.interpharma.ch/wp-content/uploads/2020/07/F%C3%BChrend-in-Wissenschaft-und-Forschung.jpg https://www.interpharma.ch/fr/blog/notre-engagement-dans-cette-situation-particuliere-5-5-place-de-production-pharmaceutique/ 2026-03-03T09:00:13+00:00 https://www.interpharma.ch/wp-content/uploads/2020/07/Interpharma_Titelbild_Home_Icon_05.jpg https://www.interpharma.ch/wp-content/uploads/2020/11/Animal-Welfare-Report-2021-EN1.pdf https://www.interpharma.ch/fr/blog/nouveaux-faits-et-chiffres-sur-le-systeme-de-sante-et-le-paysage-pharmaceutique-suisses/ 2026-03-03T09:00:31+00:00 https://www.interpharma.ch/wp-content/uploads/2022/09/thmb-Panorama.png https://www.interpharma.ch/fr/blog/communique-de-presse-place-pharmaceutique-suisse-a-la-croisee-des-chemins-la-nouvelle-realite-geopolitique-requiert-dagir-rapidement/ 2026-03-03T09:20:09+00:00 https://www.interpharma.ch/wp-content/uploads/2020/07/F%C3%BChrend-in-Wissenschaft-und-Forschung.jpg https://www.interpharma.ch/fr/blog/communique-de-presse-le-conseil-federal-a-t-il-oublie-le-plus-grand-probleme-de-la-place-pharmaceutique-suisse/ 2026-03-03T09:21:02+00:00 https://www.interpharma.ch/wp-content/uploads/2023/10/Bundeshaus-klein.jpg https://www.interpharma.ch/fr/blog/3-questions-a-la-nouvelle-responsable-du-comite-marche-myriam-deleone-directrice-generale-damgen-suisse/ 2026-03-03T09:21:25+00:00 https://www.interpharma.ch/wp-content/uploads/add-from-server-reloaded/L1040074-2-Bearbeitet-scaled-e1765550553239.jpg https://interpharma.ch/wp-content/uploads/2025/12/L1040074-2-Bearbeitet-683x1024.jpg https://www.interpharma.ch/fr/blog/amr-awareness-week-2025-partie-2-lavancee-insidieuse-de-lantibioresistance/ 2026-03-03T09:23:12+00:00 https://www.interpharma.ch/wp-content/uploads/2021/11/Blog-thumbnail-scaled.png https://www.interpharma.ch/fr/blog/communique-de-presse-la-suisse-devient-pays-de-reference-pour-les-prix-des-medicaments-aux-etats-unis-il-est-urgent-dagir/ 2026-03-03T09:23:36+00:00 https://www.interpharma.ch/wp-content/uploads/2025/08/iStock-1138801190_CH-USA.jpg https://www.interpharma.ch/fr/blog/serie-de-blogs-sur-le-moniteur-de-la-sante-2025-dinterpharma-partie-3-la-perception-des-couts-et-les-faits-ne-concordent-pas-toujours/ 2026-03-03T09:23:50+00:00 https://www.interpharma.ch/wp-content/uploads/2025/11/Screenshot-2025-11-03-090716.png https://interpharma.ch/wp-content/uploads/2025/11/image-6.png https://interpharma.ch/wp-content/uploads/2025/11/image-7.png https://www.interpharma.ch/fr/blog/serie-de-blogs-sur-le-moniteur-de-la-sante-2025-dinterpharma-partie-2-bonne-qualite-mais-potentiel-damelioration/ 2026-03-03T09:23:59+00:00 https://www.interpharma.ch/wp-content/uploads/2025/11/Screenshot-2025-11-03-090716.png https://interpharma.ch/wp-content/uploads/2025/11/image-2.png https://interpharma.ch/wp-content/uploads/2025/11/image-3.png https://www.interpharma.ch/fr/blog/serie-de-blogs-sur-le-moniteur-de-la-sante-2025-dinterpharma-partie-1-un-quart-de-siecle/ 2026-03-03T09:24:11+00:00 https://www.interpharma.ch/wp-content/uploads/2025/11/Screenshot-2025-11-03-090716.png https://www.interpharma.ch/fr/blog/communique-de-presse-nouvelle-contribution-significative-de-la-pharma-a-la-maitrise-des-couts-quand-la-securite-dapprovisionnement-est-menacee/ 2026-03-03T09:24:21+00:00 https://www.interpharma.ch/wp-content/uploads/2025/07/iStock-1944747642.jpg https://interpharma.ch/wp-content/uploads/2025/10/image-3-1024x123.png https://www.interpharma.ch/fr/blog/innovation-numerique-chez-takeda-entretien-avec-jerome-veyret-head-of-business-excellence-strategy-transformation/ 2026-03-03T09:24:31+00:00 https://www.interpharma.ch/wp-content/uploads/2025/10/Jerome-Veyret-scaled.jpg https://www.interpharma.ch/fr/blog/communique-de-presse-nouvelle-enquete-sur-leurope-2025-les-intentions-de-vote-sur-les-accords-bilateraux-iii-montrent-une-large-majorite-de-oui/ 2026-03-03T09:24:48+00:00 https://www.interpharma.ch/wp-content/uploads/2025/09/Screenshot-2025-09-09-105829.png https://www.interpharma.ch/fr/blog/communique-de-presse-pour-la-suisse-lheure-est-grave-il-faut-a-present-une-offensive-pour-la-place-suisse/ 2026-03-03T09:25:03+00:00 https://www.interpharma.ch/wp-content/uploads/2025/08/iStock-1138801190_CH-USA.jpg https://www.interpharma.ch/fr/blog/value-based-healthcare-pourquoi-nous-devrions-avoir-le-courage-de-repenser-le-systeme-de-sante/ 2026-03-03T09:25:11+00:00 https://www.interpharma.ch/wp-content/uploads/2025/06/Screenshot-2025-06-05-130443.png https://www.interpharma.ch/fr/blog/communique-de-presse-bilaterales-iii-relations-stables-avec-le-principal-partenaire-commercial/ 2026-03-03T09:25:21+00:00 https://www.interpharma.ch/wp-content/uploads/2024/03/CH_EU_generisch-klein-scaled.jpg https://www.interpharma.ch/fr/blog/communique-de-presse-lindustrie-pratiquant-la-recherche-prend-note-de-la-conclusion-de-laccord-de-libre-echange-avec-le-mercosur/ 2026-03-03T09:25:41+00:00 https://www.interpharma.ch/wp-content/uploads/2025/07/EFTA-Mercosur.jpg https://interpharma.ch/wp-content/uploads/2025/07/image-2.png https://www.interpharma.ch/fr/blog/production-pharma-de-pointe-en-suisse-assurer-linnovation-maintenir-la-competitivite/ 2026-03-03T09:25:51+00:00 https://www.interpharma.ch/wp-content/uploads/2025/06/Bild-FR.png https://www.interpharma.ch/fr/blog/communique-de-presse-acces-aux-nouveaux-medicaments-la-suisse-continue-de-perdre-du-terrain-la-prise-en-charge-des-patient-e-s-et-la-place-suisse-sont-en-danger/ 2026-03-03T09:25:59+00:00 https://www.interpharma.ch/wp-content/uploads/2021/02/iStock-1064859060-scaled.jpg https://www.interpharma.ch/fr/blog/medienmitteilung-bilaterale-iii-exportstandort-sichern-fuer-eine-international-vernetzte-souveraene-schweiz/ 2026-03-03T09:26:10+00:00 https://www.interpharma.ch/fr/blog/3-questions-a-nos-nouveaux-membres-du-conseil-dadministration-iris-zemzoum-president-region-europe-chez-novartis-et-vice-president-du-conseil-dadministration/ 2026-03-03T09:26:22+00:00 https://www.interpharma.ch/wp-content/uploads/2025/06/Beitragsbild_3-Fragen-an-Iris-Zemzoum.png https://interpharma.ch/wp-content/uploads/2025/06/Photo-Iris-Zemzoum-2.jpg https://www.interpharma.ch/fr/blog/communique-de-presse-concentration-sur-la-qualite-plutot-que-la-quantite-comment-le-value-based-healthcare-peut-assurer-la-perennite-du-systeme-de-sante-suisse/ 2026-03-03T09:26:33+00:00 https://www.interpharma.ch/wp-content/uploads/2025/06/Screenshot-2025-06-05-130443.png https://interpharma.ch/wp-content/uploads/2025/06/image-1.png https://www.interpharma.ch/fr/blog/3-fragen-an-unsere-neuen-boardmitglieder-florian-saur-country-general-manager-switzerland-astrazeneca/ 2026-03-03T09:26:43+00:00 https://www.interpharma.ch/wp-content/uploads/2025/06/AZ_Florian-Saur_1-scaled.jpg https://interpharma.ch/wp-content/uploads/2025/06/AZ_Florian-Saur_1-1024x683.jpg https://www.interpharma.ch/fr/blog/3-questions-a-nos-nouveaux-membres-du-conseil-dadministration-annette-luther-head-external-affairs-switzerland-chez-roche/ 2026-03-03T09:26:55+00:00 https://www.interpharma.ch/wp-content/uploads/2025/05/Beitragsbild_Annette-Luther_3-Fraqgen-an.png https://interpharma.ch/wp-content/uploads/2025/05/Annette_Luther_Roche_02-1-819x1024.jpg https://www.interpharma.ch/fr/blog/3-questions-a-nos-nouveaux-membres-du-conseil-dadministration-linn-mandahl-vice-president-europe-region-south-chez-abbvie/ 2026-03-03T09:27:04+00:00 https://www.interpharma.ch/wp-content/uploads/2025/05/Beitragsbild-3-Fragen-an-Linn-Mandahl-1.png https://interpharma.ch/wp-content/uploads/2025/05/Linn-Mandahl-3-683x1024.jpg https://www.interpharma.ch/fr/blog/3-questions-a-nos-nouveaux-membres-du-comite-david-traub-directeur-de-novartis-pharma-schweiz-ag/ 2026-03-03T09:27:19+00:00 https://www.interpharma.ch/wp-content/uploads/2025/05/Beitragsbild-3-Fragen-an-David-Traub-1.png https://interpharma.ch/wp-content/uploads/2025/05/David-Traub-3-748x1024.jpg https://www.interpharma.ch/fr/blog/le-contre-projet-a-linitiative-pour-un-frein-aux-couts-fait-fi-de-la-decision-du-parlement-et-renforce-la-pensee-en-silos/ 2026-03-03T09:27:30+00:00 https://www.interpharma.ch/wp-content/uploads/2023/10/Bundeshaus-klein.jpg https://www.interpharma.ch/fr/blog/lintegration-des-medicaments-innovants-dans-les-forfaits-ambulatoires-met-en-danger-la-qualite-et-linnovation/ 2026-03-03T09:27:38+00:00 https://www.interpharma.ch/wp-content/uploads/2025/04/iStock-529498283_Gesundheitswesen-und-Kosten.jpg https://www.interpharma.ch/fr/blog/medienmitteilung-standortwettbewerb-verschaerft-sich-jetzt-braucht-es-eine-schweizer-life-science-strategie/ 2026-03-03T09:27:56+00:00 https://www.interpharma.ch/wp-content/uploads/2022/03/iStock-1293772969.jpg https://www.interpharma.ch/fr/blog/la-prevention-dans-le-systeme-de-sante-suisse/ 2026-03-03T09:28:04+00:00 https://www.interpharma.ch/wp-content/uploads/2025/04/Les-reins-suffrent-en-silence-1.png https://interpharma.ch/wp-content/uploads/2025/04/Les-reins-suffrent-en-silence-1024x439.png https://www.interpharma.ch/fr/blog/acces-a-linnovation-dans-les-domaines-de-la-prevention-et-du-depistage-precoce/ 2026-03-03T09:28:13+00:00 https://www.interpharma.ch/wp-content/uploads/2025/04/iStock_Herz_Praevention.jpg https://www.interpharma.ch/fr/blog/lutilisation-des-donnees-comme-cle-dune-prevention-plus-ciblee/ 2026-03-03T09:28:22+00:00 https://www.interpharma.ch/wp-content/uploads/2025/04/NF_AI4HealthyCities_Skyline_Banner-scaled.jpg https://www.interpharma.ch/fr/blog/strategie-et-coordination-globales/ 2026-03-03T09:28:29+00:00 https://www.interpharma.ch/wp-content/uploads/2025/04/Bild_Blogbeitrag-2.png https://www.interpharma.ch/fr/blog/une-prevention-ciblee-et-une-detection-precoce-comme-cles-de-la-reussite-a-long-terme/ 2026-03-03T09:28:38+00:00 https://www.interpharma.ch/wp-content/uploads/2025/04/Beitragsbild-franzoesisch-1.png https://www.interpharma.ch/fr/blog/la-prevention-comme-element-dun-systeme-de-sante-suisse-perenne/ 2026-03-03T09:28:49+00:00 https://www.interpharma.ch/wp-content/uploads/2025/04/Prinzipien-des-Gesundheitswesens_slide_FR-scaled.png https://www.interpharma.ch/fr/blog/journee-de-lindustrie-pharmaceutique-2025-renforcer-la-competitivite-de-lindustrie-pharmaceutique-suisse/ 2026-03-03T09:29:24+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/bild_schweiz-EU_kachel_380x150.jpg https://www.interpharma.ch/fr/blog/medienmitteilung-daiichi-sankyo-wird-mitglied-bei-interpharma/ 2026-03-03T09:29:38+00:00 https://www.interpharma.ch/wp-content/uploads/2025/04/Ausschnitt-Jahresbericht-2024.jpg https://www.interpharma.ch/fr/blog/2e-volet-de-mesures-visant-a-freiner-la-hausse-des-couts-un-bilan-extremement-douteux/ 2026-03-03T09:29:46+00:00 https://www.interpharma.ch/wp-content/uploads/2023/09/KP2_klein.png https://www.interpharma.ch/fr/blog/medienmitteilung-europabefragung-2025-die-schweizer-bevoelkerung-befuerwortet-das-ergebnis-der-verhandlungen-mit-der-eu-trotz-einiger-unsicherheiten/ 2026-03-03T09:29:56+00:00 https://www.interpharma.ch/wp-content/uploads/2025/03/Web-Europabefragung-2025.jpg https://www.interpharma.ch/fr/blog/communique-de-presse-le-conseil-des-etats-risque-une-crise-dapprovisionnement-en-medicaments/ 2026-03-03T09:30:06+00:00 https://www.interpharma.ch/wp-content/uploads/2023/09/KP2-FR.png https://www.interpharma.ch/fr/blog/la-croissance-du-secteur-des-medicaments-recule-les-copies-de-produits-originaux-gagnent-enormement-de-terrain/ 2026-03-03T09:30:33+00:00 https://www.interpharma.ch/wp-content/uploads/2023/01/Medikamentenproduktion.jpg https://www.interpharma.ch/fr/blog/communique-de-presse-carte-blanche-de-la-commission-du-conseil-des-etats-a-ladministration-acces-aux-medicaments-en-danger/ 2026-03-03T09:30:42+00:00 https://www.interpharma.ch/wp-content/uploads/2023/09/KP2-FR.png https://www.interpharma.ch/fr/blog/lung-on-chip-eine-humane-loesung-zur-pruefung-von-lungenfunktion-und-toxizitaet/ 2026-03-03T09:30:51+00:00 https://www.interpharma.ch/wp-content/uploads/2025/01/2021-3RCC-026-scaled.jpg https://www.interpharma.ch/fr/blog/la-suisse-ne-doit-avoir-de-cesse-de-sameliorer/ 2026-03-03T09:30:58+00:00 https://www.interpharma.ch/wp-content/uploads/2025/01/thm_FR2-1.png https://www.interpharma.ch/fr/blog/douloureuses-economies-pour-lindustrie-pharmaceutique-le-conseil-national-envoie-un-signal-en-faveur-de-la-securite-de-lapprovisionnement/ 2026-03-03T09:31:22+00:00 https://www.interpharma.ch/wp-content/uploads/2023/09/KP2-FR.png https://www.interpharma.ch/fr/blog/blogserie-mit-dem-3rcc-teil-9-neue-therapien-im-fokus-wie-bahnbrechende-tierversuchsfreie-forschung-den-weg-zur-behandlung-der-fettleber-ebnet/ 2026-03-03T09:31:47+00:00 https://www.interpharma.ch/wp-content/uploads/2024/11/BIld-Artikel-9-Liver_organoid-scaled.jpg https://www.interpharma.ch/fr/blog/blogserie-mit-dem-3rcc-teil-8-koennen-insekten-emotionen-empfinden-neue-studien-entfachen-eine-debatte-ueber-die-schmerzempfindlichkeit-wirbelloser-lebewesen/ 2026-03-03T09:31:53+00:00 https://www.interpharma.ch/wp-content/uploads/2024/10/Artikel-8-AdobeStock_741829926-scaled.jpeg https://www.interpharma.ch/fr/blog/medienmitteilung-kostendaempfungspaket-2-erneut-einschneidende-sparmassnahmen-zulasten-der-pharmaindustriemedienmitteilung/ 2026-03-03T09:32:02+00:00 https://www.interpharma.ch/wp-content/uploads/2023/09/KP2-FR.png https://www.interpharma.ch/fr/blog/blogserie-mit-dem-3rcc-teil-7-neue-methode-simuliert-echte-gewebestrukturen-ein-grosser-schritt-fuer-die-zukunft-der-krebsforschung/ 2026-03-03T09:32:11+00:00 https://www.interpharma.ch/wp-content/uploads/2024/10/Artikel-7-pdac_ck7_dapi_day13.png https://www.interpharma.ch/fr/blog/financement-uniforme-pour-un-systeme-de-sante-plus-juste-et-plus-efficace/ 2026-03-03T09:32:36+00:00 https://www.interpharma.ch/wp-content/uploads/2024/10/ef_sujet_messages_16x9_FR-1.jpg https://interpharma.ch/wp-content/uploads/2024/10/20240925_EF_Grafik-2_IT_01-1024x455.jpg https://www.interpharma.ch/fr/blog/versorgungssicherheit-in-der-schweiz-herausforderungen-und-strategien-fuer-die-zukunft/ 2026-03-03T09:32:51+00:00 https://www.interpharma.ch/wp-content/uploads/2024/10/Titelbild.jpg https://interpharma.ch/wp-content/uploads/2024/09/Bild1-1024x700.png https://interpharma.ch/wp-content/uploads/2024/09/Bild2-1-1024x767.png https://www.interpharma.ch/fr/blog/blogserie-mit-dem-3rcc-teil-6-wachstumswunder-wie-radial-verteilte-stammzellen-das-wachstum-von-organoiden-foerdern/ 2026-03-03T09:33:01+00:00 https://www.interpharma.ch/wp-content/uploads/2024/09/Bild-Artikel-6-OCTOPUS-THUMBNAIL.png https://www.interpharma.ch/fr/blog/sommerblogserie-mit-dem-3rcc-teil-5-3d-gedrucktes-modell-revolutioniert-die-krebsforschung/ 2026-03-03T09:33:13+00:00 https://www.interpharma.ch/wp-content/uploads/2024/09/iStock-1530776415.jpg https://www.interpharma.ch/fr/blog/hightech-pharmaproduktion-in-der-schweizer-pharmaindustrie-innovation-und-effizienz/ 2026-03-03T09:33:28+00:00 https://www.interpharma.ch/wp-content/uploads/2024/09/Anzeigebild-F.jpg https://www.interpharma.ch/fr/blog/naeher-an-der-loesung-des-praeeklampsie-raetsels-in-vitro-trophoblastzellen-in-aktion/ 2026-03-03T09:33:38+00:00 https://www.interpharma.ch/wp-content/uploads/2024/09/2023-Swiss3RCC-003-low.jpg https://www.interpharma.ch/fr/blog/communique-de-presse-panorama-de-la-sante-2024-contribution-factuelle-au-dialogue-en-faveur-dun-systeme-de-sante-davenir/ 2026-03-03T09:33:58+00:00 https://www.interpharma.ch/wp-content/uploads/2024/08/Front-FR.png https://interpharma.ch/wp-content/uploads/2024/08/en-bref-1024x691.png https://www.interpharma.ch/fr/blog/medienmitteilung-europabefragung-2024-die-schweizer-stimmbevoelkerung-steht-klar-hinter-den-bilateralen-und-zeigt-sich-kompromissbereit/ 2026-03-03T09:34:34+00:00 https://www.interpharma.ch/wp-content/uploads/2024/03/CH_EU_generisch-klein-scaled.jpg https://www.interpharma.ch/fr/blog/sommerblogserie-zusammen-mit-dem-3rcc-teil-3-das-gehirn-und-die-zeit-was-fruchtfliegen-uns-verraten/ 2026-03-03T09:34:51+00:00 https://www.interpharma.ch/wp-content/uploads/2024/08/FlyCircadianRhythm.png https://interpharma.ch/wp-content/uploads/2024/08/FlyCircadianRhythm-1024x576.png https://www.interpharma.ch/fr/blog/communique-de-presse-2e-volet-de-mesures-visant-a-freiner-la-hausse-des-couts-la-commission-de-la-sante-du-national-procede-a-des-rectifications-importantes/ 2026-03-03T09:35:43+00:00 https://www.interpharma.ch/wp-content/uploads/2023/09/KP2-FR.png https://www.interpharma.ch/fr/blog/serie-de-blogs-sur-le-moniteur-de-la-sante-2024-dinterpharma-partie-2-la-population-suisse-apprecie-la-qualite-du-systeme-de-sante-suisse/ 2026-03-03T09:36:24+00:00 https://www.interpharma.ch/wp-content/uploads/2024/06/Titelbild-Gesundheitsmonitor-2024-F.jpg https://interpharma.ch/wp-content/uploads/2024/08/03f-1024x893.png https://interpharma.ch/wp-content/uploads/2024/08/06f-1024x778.png https://interpharma.ch/wp-content/uploads/2024/08/15f-1024x721.png https://interpharma.ch/wp-content/uploads/2024/08/16f-1024x815.png https://www.interpharma.ch/fr/blog/blogserie-interpharma-gesundheitsmonitor-2024-teil-1-zunehmender-roestigraben-bei-gesundheitsfragen/ 2026-03-03T09:36:42+00:00 https://www.interpharma.ch/wp-content/uploads/2024/06/Titelbild-Gesundheitsmonitor-2024-D.jpg https://interpharma.ch/wp-content/uploads/2024/08/01f-1024x695.png https://interpharma.ch/wp-content/uploads/2024/08/02f-1024x695.png https://interpharma.ch/wp-content/uploads/2024/08/11f-1024x790.png https://interpharma.ch/wp-content/uploads/2024/08/12-1024x837.png https://www.interpharma.ch/fr/blog/sommerblogserie-zusammen-mit-dem-3rcc-teil-2-erforschung-von-blutstammzellen-erkenntnisse-aus-bildgebenden-verfahren-ueber-die-entwicklung-von-zebrafischen/ 2026-03-03T09:36:53+00:00 https://www.interpharma.ch/wp-content/uploads/2024/07/Zebrafisch.png https://www.interpharma.ch/fr/blog/communique-de-presse-lapprovisionnement-en-medicaments-est-en-danger-le-marche-suisse-perd-de-son-attrait/ 2026-03-03T09:37:02+00:00 https://www.interpharma.ch/wp-content/uploads/2024/07/Therapie.jpg https://interpharma.ch/wp-content/uploads/2024/07/Benchmarking_FR-1024x523.png https://www.interpharma.ch/fr/blog/sommerblogserie-zusammen-mit-dem-3rcc-teil-1-wie-darmbakterien-das-sozialverhalten-von-zebrafischen-beeinflussen/ 2026-03-03T09:37:11+00:00 https://www.interpharma.ch/wp-content/uploads/2024/07/Zebrafisch.png https://interpharma.ch/wp-content/uploads/2024/07/Zebrafisch.png https://www.interpharma.ch/fr/blog/3-fragen-an-unsere-neuen-boardmitglieder-florian-schick-president-merck-switzerland/ 2026-03-03T09:37:25+00:00 https://www.interpharma.ch/wp-content/uploads/2024/07/Schick_1_klein.jpg https://interpharma.ch/wp-content/uploads/2024/07/Schick_1-1024x1024.jpg https://www.interpharma.ch/fr/blog/communique-de-presse-les-patientes-et-patients-font-les-frais-des-decisions/ 2026-03-03T09:37:37+00:00 https://www.interpharma.ch/wp-content/uploads/2023/09/KP2-FR.png https://www.interpharma.ch/fr/blog/communique-de-presse-le-conseil-des-etats-met-en-danger-lacces-des-patient-e-scommunique-de-presse/ 2026-03-03T09:38:00+00:00 https://www.interpharma.ch/wp-content/uploads/2023/09/KP2-FR.png https://www.interpharma.ch/fr/blog/interpharma-gesundheitsmonitor-2024-zeigt-roesti-graben-bei-gesundheitsfragen-in-der-schweizer-bevoelkerung/ 2026-03-03T09:38:08+00:00 https://www.interpharma.ch/wp-content/uploads/2024/06/Titelbild-Gesundheitsmonitor-2024-F.jpg https://www.interpharma.ch/fr/blog/communique-de-presse-disponibilite-des-medicaments-la-suisse-perd-du-terrain/ 2026-03-03T09:38:17+00:00 https://www.interpharma.ch/wp-content/uploads/2024/06/Wait_F2-2.png https://interpharma.ch/wp-content/uploads/2024/06/WAIT_F-1.png https://www.interpharma.ch/fr/blog/des-approches-globales-dans-le-systeme-de-sante-sont-plus-urgentes-que-jamais/ 2026-03-03T09:38:26+00:00 https://www.interpharma.ch/wp-content/uploads/2024/06/Vorschaubild_FR-scaled.png https://www.interpharma.ch/fr/blog/communique-de-presse-comparaison-de-prix-des-medicaments-avec-letranger-augmentation-de-lecart-differences-importantes-sur-les-generiques-et-les-biosimilaires/ 2026-03-03T09:38:36+00:00 https://www.interpharma.ch/wp-content/uploads/2024/05/Titelbild_MM_APV_F.jpg https://www.interpharma.ch/fr/blog/communique-de-presse-par-sa-decision-hative-sur-les-modeles-dimpact-budgetaire-la-commission-du-conseil-des-etats-met-en-danger-lacces-des-patient-e-s/ 2026-03-03T09:38:50+00:00 https://www.interpharma.ch/wp-content/uploads/2023/09/KP2-FR.png https://www.interpharma.ch/fr/blog/medienmitteilung-tag-der-pharmazeutischen-industrie-2024-was-es-fuer-ein-innovationsoekosystem-schweiz-braucht/ 2026-03-03T09:39:06+00:00 https://www.interpharma.ch/wp-content/uploads/2024/04/Titelbild-Jahresbericht-2023-D.png https://www.interpharma.ch/fr/blog/medienmitteilung-generalversammlung-von-interpharma-2/ 2026-03-03T09:39:15+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/blog-image-002.jpg https://www.interpharma.ch/fr/blog/medienmitteilung-interpharma-nimmt-den-abschluss-des-freihandelsabkommens-mit-indien-zur-kenntnis/ 2026-03-03T09:39:25+00:00 https://www.interpharma.ch/wp-content/uploads/2024/03/CH-INdien.jpg https://www.interpharma.ch/fr/blog/medienmitteilung-der-bilaterale-weg-soll-weitergehen/ 2026-03-03T09:39:34+00:00 https://www.interpharma.ch/wp-content/uploads/2024/03/CH_EU_generisch-klein-scaled.jpg https://www.interpharma.ch/fr/blog/medienmitteilung-interpharma-unterstuetzt-den-entwurf-des-verhandlungsmandats/ 2026-03-03T09:39:43+00:00 https://www.interpharma.ch/wp-content/uploads/2023/04/CH_EU_generisch-scaled.jpg https://www.interpharma.ch/fr/blog/communique-de-presse-croissance-du-marche-du-medicament-nettement-ralentie-par-les-baisses-de-prix/ 2026-03-03T09:39:52+00:00 https://www.interpharma.ch/wp-content/uploads/2023/01/Medikamentenproduktion.jpg https://www.interpharma.ch/fr/blog/medienmitteilung-die-pharmabranche-ist-der-motor-der-schweizer/ 2026-03-03T09:40:01+00:00 https://www.interpharma.ch/wp-content/uploads/2024/01/Bedeutungstudie-2024-F-Bild-MM.jpg https://www.interpharma.ch/fr/blog/communique-de-presse-etape-majeure-franchie-en-politique-de-la-sante-le-parlement-adopte-efas/ 2026-03-03T09:40:10+00:00 https://www.interpharma.ch/wp-content/uploads/2023/12/EFAS_Ja_Entscheid.jpeg https://www.interpharma.ch/fr/blog/medienmitteilung-breite-zustimmung-in-der-stimmbevoelkerung-fuer-ein-verhandlungsmandat-zu-den-bilateralen-iii/ 2026-03-03T09:40:19+00:00 https://www.interpharma.ch/wp-content/uploads/2023/12/Umfrsge-Europa-Bilaterale-3.jpg https://www.interpharma.ch/fr/blog/medienmitteilung-eu-verhandlungsmandat-ein-wichtiger-meilenstein-fuer-die-stabilisierung-der-bilateralen-beziehungen/ 2026-03-03T09:40:30+00:00 https://www.interpharma.ch/wp-content/uploads/2023/04/CH_EU_generisch-scaled.jpg https://www.interpharma.ch/fr/blog/communique-de-presse-marges-lindustrie-accepte-de-nouvelles-economies-mais-lacces-des-patients-est-en-danger/ 2026-03-03T09:40:38+00:00 https://www.interpharma.ch/wp-content/uploads/2022/09/iStock-170160380.jpg https://interpharma.ch/wp-content/uploads/2023/12/iph_panorama_F_S24-1024x683.png https://interpharma.ch/wp-content/uploads/2023/12/1fr-1024x583.png https://interpharma.ch/wp-content/uploads/2023/12/2fr.png https://interpharma.ch/wp-content/uploads/2023/12/3fr.png https://www.interpharma.ch/fr/blog/medienmitteilung-digisante-eine-chance-um-den-rueckstand-bei-der-digitalisierung-des-schweizer-gesundheitswesens-aufzuholen/ 2026-03-03T09:40:59+00:00 https://www.interpharma.ch/wp-content/uploads/2023/11/Digitalisierung-allgemein-1-scaled.jpg https://www.interpharma.ch/fr/blog/elections-2023-evaluation-dinterpharma/ 2026-03-03T09:41:43+00:00 https://www.interpharma.ch/wp-content/uploads/2023/10/Bundeshaus-klein.jpg https://www.interpharma.ch/fr/blog/serie-sustainable-development-goals-johnson-johnson-engagiert-sich-fuer-klimaschutz-mit-konkreten-projekten/ 2026-03-03T09:42:48+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/blog-image-076-scaled.jpg https://www.interpharma.ch/fr/blog/communique-de-presse-deuxieme-volet-de-mesures-visant-a-freiner-la-hausse-des-couts-etape-importante-pour-lacces-des-patient-e-s-et-la-securite-dapprovisionnement/ 2026-03-03T09:42:55+00:00 https://www.interpharma.ch/wp-content/uploads/2023/09/KP2-FR.png https://www.interpharma.ch/fr/blog/panorama-de-la-sante-2023-puissions-nous-connaitre-90-annees-supplementaires-dinnovation-et-de-qualite-dans-le-domaine-de-la-sante/ 2026-03-03T09:43:26+00:00 https://www.interpharma.ch/wp-content/uploads/2023/08/Cover-FR.png https://interpharma.ch/wp-content/uploads/2023/08/Bullets-FR.png https://www.interpharma.ch/fr/blog/communique-de-presse-il-faut-a-present-des-progres-rapides-pour-stabiliser-les-relations-bilaterales/ 2026-03-03T09:43:45+00:00 https://www.interpharma.ch/wp-content/uploads/2023/04/CH_EU_generisch-scaled.jpg https://www.interpharma.ch/fr/blog/medienmitteilung-gesundheitsmonitor-2023-zeigt-schweizer-bevoelkerung-fordert-einen-schnelleren-zugang-zu-innovativen-medikamenten/ 2026-03-03T09:44:03+00:00 https://www.interpharma.ch/wp-content/uploads/2023/06/Gesundheitsmonitor-2023-F.jpg https://www.interpharma.ch/fr/blog/internationaler-tag-der-klinischen-forschung-3-fragen-an-prof-dr-med-miklos-pless-praesident-sakk/ 2026-03-03T09:44:19+00:00 https://www.interpharma.ch/wp-content/uploads/2023/05/Pless-Miklos.jpg https://www.interpharma.ch/fr/blog/communique-de-presse-comparaison-du-prix-des-medicaments-avec-letranger-ecarts-de-prix-significatifs-pour-les-generiques-et-les-biosimilaires-legere-baisse-pour-les-preparations-o/ 2026-03-03T09:44:31+00:00 https://www.interpharma.ch/wp-content/uploads/2023/05/APV_f.png https://www.interpharma.ch/fr/blog/3-fragen-an-thorsten-hein-mitglied-interpharma-board-und-country-division-head-pharmaceuticals-bayer-schweiz/ 2026-03-03T09:44:43+00:00 https://www.interpharma.ch/wp-content/uploads/2021/11/ThorstenHein.neu_.png https://www.interpharma.ch/fr/blog/3-fragen-an-graham-dorey-mitglied-interpharma-board-und-general-manager-schweiz-biogen/ 2026-03-03T09:44:52+00:00 https://www.interpharma.ch/wp-content/uploads/2023/05/dorey_741_highres-1-scaled.jpg https://www.interpharma.ch/fr/blog/3-fragen-an-max-pahlow-mitglied-interpharma-board-und-managing-director-janssen-switzerland/ 2026-03-03T09:45:00+00:00 https://www.interpharma.ch/wp-content/uploads/2023/04/klein_MAX-PAHLOW18753.jpg https://www.interpharma.ch/fr/blog/medienmitteilung-ueberarbeitung-der-allgemeinen-eu-arzneimittelvorschriften-schwerwiegende-konsequenzen-fuer-die-schweiz-erwartet/ 2026-03-03T09:45:10+00:00 https://www.interpharma.ch/wp-content/uploads/2023/04/CH_EU_generisch-scaled.jpg https://www.interpharma.ch/fr/blog/3-fragen-an-pierre-morneau-general-manager-takeda-schweiz-takeda-pharma-ag-vice-chair-innovation-hub-committee/ 2026-03-03T09:45:18+00:00 https://www.interpharma.ch/wp-content/uploads/2023/04/896_Interpharma-scaled.jpg https://www.interpharma.ch/fr/blog/decouvrez-la-place-pharmaceutique-suisse-de-maniere-interactive/ 2026-03-03T09:45:33+00:00 https://www.interpharma.ch/wp-content/uploads/2023/04/thm_FR.jpg https://www.interpharma.ch/fr/blog/communique-de-presse-interpharma-90-ans-dinnovation-et-dengagement-au-service-des-patientes-et-patients-de-suisse/ 2026-03-03T09:45:50+00:00 https://www.interpharma.ch/wp-content/uploads/2023/03/Logo_90-Jahre.jpg https://www.interpharma.ch/fr/blog/medienmitteilung-generalversammlung-von-interpharma/ 2026-03-03T09:46:01+00:00 https://www.interpharma.ch/wp-content/uploads/2023/03/Jahresbericht-2022-Titelbild-EN.jpg https://www.interpharma.ch/fr/blog/medienmitteilung-europabefragung-2023-schweizer-bevoelkerung-unterstuetzt-bilaterale-noch-staerker-und-erwartet-vom-bundesrat-einen-konkreten-vorschlag/ 2026-03-03T09:46:10+00:00 https://www.interpharma.ch/wp-content/uploads/2023/03/Europabefragung-2023.jpg https://www.interpharma.ch/fr/blog/communique-de-presse-croissance-du-marche-des-medicaments-a-nouveau-nettement-freinee-par-les-baisses-de-prix/ 2026-03-03T09:46:25+00:00 https://www.interpharma.ch/wp-content/uploads/2023/01/Medikamentenproduktion.jpg https://www.interpharma.ch/fr/blog/communique-de-presse-les-commissions-de-la-securite-sociale-et-de-la-sante-publique-du-conseil-national-et-du-conseil-des-etats-envoient-un-signal-fort-et-reconnaissent-aussi-une-necessite-d/ 2026-03-03T09:46:35+00:00 https://www.interpharma.ch/wp-content/uploads/2023/01/Revision-KVVKLV_small_FR.png https://www.interpharma.ch/fr/blog/die-erosion-geht-weiter-der-bundesrat-sieht-keinen-handlungsbedarf-zur-staerkung-des-schweizer-pharmastandortes-leider/ 2026-03-03T09:46:48+00:00 https://www.interpharma.ch/wp-content/uploads/2020/05/Bundeshaus-scaled.jpg https://interpharma.ch/wp-content/uploads/2023/01/iph_panorama22_F_S72-1024x683.png https://www.interpharma.ch/fr/blog/serie-de-blogs-sur-la-conference-de-presse-annuelle-dinterpharma-partie-3-acces-des-patient-e-s-il-faut-un-equilibre-entre-la-qualite-les-couts-et-la-securite-dapprovisi/ 2026-03-03T09:46:58+00:00 https://www.interpharma.ch/wp-content/uploads/2023/01/443_Interpharma-scaled.jpg https://interpharma.ch/wp-content/uploads/2023/01/image-13.png https://interpharma.ch/wp-content/uploads/2023/01/image-14-1024x467.png https://interpharma.ch/wp-content/uploads/2023/01/image-15.png https://interpharma.ch/wp-content/uploads/2023/01/image-16-1024x542.png https://interpharma.ch/wp-content/uploads/2023/01/image-17-1024x594.png https://www.interpharma.ch/fr/blog/serie-de-blogs-sur-la-conference-de-presse-annuelle-dinterpharma-partie-2-une-place-pharmaceutique-forte-un-acces-fort-des-patientes-et-patients/ 2026-03-03T09:47:13+00:00 https://www.interpharma.ch/wp-content/uploads/2023/01/Katrien-De-Vos-Kopie-scaled.jpg https://interpharma.ch/wp-content/uploads/2023/01/image-9-1024x591.png https://interpharma.ch/wp-content/uploads/2023/01/image-8-1024x590.png https://interpharma.ch/wp-content/uploads/2023/01/image-10-1024x584.png https://interpharma.ch/wp-content/uploads/2023/01/image-11-1024x565.png https://interpharma.ch/wp-content/uploads/2023/01/image-12-1024x569.png https://www.interpharma.ch/fr/blog/serie-de-blogs-sur-la-conference-de-presse-annuelle-dinterpharma-partie-1-la-place-pharmaceutique-suisse-a-besoin-de-mise-en-reseau/ 2026-03-03T09:47:29+00:00 https://www.interpharma.ch/wp-content/uploads/2023/01/Grupp-Schwaechere-Qualitaet.jpg https://www.interpharma.ch/fr/blog/communique-de-presse-un-succes-pour-la-place-suisse-et-la-securite-dapprovisionnement/ 2026-03-03T09:47:37+00:00 https://www.interpharma.ch/wp-content/uploads/2022/12/CH-USA-scaled.jpg https://www.interpharma.ch/fr/blog/un-defi-toujours-plus-grand-lindustrie-pharmaceutique-reste-tributaire-de-conditions-cadres-attrayantes/ 2026-03-03T09:47:46+00:00 https://www.interpharma.ch/wp-content/uploads/2023/01/thmb_JPK.jpg https://www.interpharma.ch/fr/blog/les-adpic-en-bref/ 2026-03-03T09:47:59+00:00 https://www.interpharma.ch/wp-content/uploads/2021/10/IP-scaled.jpg https://www.interpharma.ch/fr/blog/gute-nachrichten-fuer-den-produktionsstandort-schweiz/ 2026-03-03T09:48:08+00:00 https://www.interpharma.ch/wp-content/uploads/2022/12/CH-USA-scaled.jpg https://www.interpharma.ch/fr/blog/maitrise-des-couts-lindustrie-pharmaceutique-accepte-les-modeles-de-prix-pour-autant-que-lacces-des-patient-e-s-sameliore/ 2026-03-03T09:48:16+00:00 https://www.interpharma.ch/wp-content/uploads/2022/12/Komplexitaet_iStock-1061344204.jpg https://interpharma.ch/wp-content/uploads/2022/12/Komplexitaet_iStock-1061344204-1024x683.jpg https://www.interpharma.ch/fr/blog/blogserie-animal-welfare-report-2022-teil-3-auf-dem-weg-vom-zuchtbetrieb-zum-labor-steht-das-tierwohl-an-erster-stelle/ 2026-03-03T09:48:48+00:00 https://www.interpharma.ch/wp-content/uploads/2022/11/AWR-22-Website-1.jpg https://www.interpharma.ch/fr/blog/blogserie-animal-welfare-report-2022-teil-2-notwendige-tierversuche-und-die-ubertragbarkeit-der-ergebnisse-auf-den-menschen-ii/ 2026-03-03T09:49:00+00:00 https://www.interpharma.ch/wp-content/uploads/2022/11/AWR-22-Website-1.jpg https://www.interpharma.ch/fr/blog/blogserie-amr-awareness-week-2022-teil-1-neue-antibiotika-sollten-als-versicherung-fuer-kuenftige-gesundheitskrisen-angesehen-werden/ 2026-03-03T09:49:11+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/blog-image-067.jpg https://www.interpharma.ch/fr/blog/medienmitteilung-animal-welfare-report-2022-tierversuche-sind-immer-noch-unerlaesslich-fuer-die-erforschung-neuer-behandlungsansaetze/ 2026-03-03T09:49:36+00:00 https://www.interpharma.ch/wp-content/uploads/2022/11/AWR-22-Website-1.jpg https://www.interpharma.ch/fr/blog/couts-de-sante-et-prix-des-medicaments-eclaircissements/ 2026-03-03T09:49:45+00:00 https://www.interpharma.ch/wp-content/uploads/2022/10/iph_panorama22_F_S14.png https://interpharma.ch/wp-content/uploads/2022/10/iph_panorama22_F_S14-1024x683.png https://interpharma.ch/wp-content/uploads/2022/10/iph_panorama22_F_S16-1024x683.png https://interpharma.ch/wp-content/uploads/2022/10/iph_panorama22_F_S15-1024x683.png https://interpharma.ch/wp-content/uploads/2022/10/iph_panorama22_F_S17-1024x683.png https://interpharma.ch/wp-content/uploads/2022/10/iph_panorama22_F_S18-1024x683.png https://interpharma.ch/wp-content/uploads/2022/10/iph_panorama22_F_S19-1024x683.png https://interpharma.ch/wp-content/uploads/2022/10/Innovation.png https://www.interpharma.ch/fr/blog/position-commune-sur-la-revision-de-la-prise-en-charge-dans-des-cas-particuliers-oamal-art-71a-a-d/ 2026-03-03T09:49:59+00:00 https://www.interpharma.ch/wp-content/uploads/2022/10/kvv_brief_F.png https://www.interpharma.ch/fr/blog/serie-de-blogs-sur-la-2e-volet-de-mesures-visant-a-freiner-la-hausse-des-couts-partie-3-comment-le-conseil-federal-elabore-ses-politiques-sans-tenir-compte-de-la-population/ 2026-03-03T09:50:13+00:00 https://www.interpharma.ch/wp-content/uploads/2022/10/image-8-e1665477357499.png https://interpharma.ch/wp-content/uploads/2022/10/image-8.png https://www.interpharma.ch/fr/blog/serie-de-blogs-sur-la-2e-volet-de-mesures-visant-a-freiner-la-hausse-des-couts-partie-2-un-mal-pour-un-autre/ 2026-03-03T09:50:21+00:00 https://www.interpharma.ch/wp-content/uploads/2022/10/image-8-e1665477357499.png https://interpharma.ch/wp-content/uploads/2022/10/image-6.png https://interpharma.ch/wp-content/uploads/2022/10/image-7.png https://www.interpharma.ch/fr/blog/communique-de-presse-interpharma-demande-la-creation-dun-cadre-juridique-national-sur-lutilisation-des-donnees-de-sante/ 2026-03-03T09:50:35+00:00 https://www.interpharma.ch/wp-content/uploads/2022/10/Grafik_f.png https://www.interpharma.ch/fr/blog/serie-de-blogs-sur-le-volet-2-1er-episode-le-secteur-pharmaceutique-soutient-les-economies-et-accepte-les-modeles-de-prix/ 2026-03-03T09:50:50+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/image-4.png https://interpharma.ch/wp-content/uploads/2022/10/image-4.png https://www.interpharma.ch/fr/blog/communique-de-presse-interpharma-rejette-categoriquement-le-projet-de-revision-de-loamal-et-de-lopas-presente-par-le-conseil-federal/ 2026-03-03T09:51:01+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/blog-image-053-scaled.jpg https://www.interpharma.ch/fr/blog/rapport-sur-le-remboursement-des-medicaments-pour-les-en-fants-atteints-dun-cancer-le-conseil-federal-cree-de-nouveaux-problemes/ 2026-03-03T09:51:20+00:00 https://www.interpharma.ch/wp-content/uploads/2022/09/iStock-1064859060-1-scaled.jpg https://www.interpharma.ch/fr/blog/deuxieme-volet-de-mesures-visant-a-freiner-la-hausse-des-couts-le-conseil-federal-manque-une-occasion-au-parlement-dameliorer-le-projet/ 2026-03-03T09:51:46+00:00 https://www.interpharma.ch/wp-content/uploads/2022/06/Notfall.jpg https://www.interpharma.ch/fr/blog/panorama-de-la-sante-une-contribution-importante-au-dialogue-sur-les-soins-de-sante-et-la-place-pharmaceutique/ 2026-03-03T09:51:56+00:00 https://www.interpharma.ch/wp-content/uploads/2022/09/thmb-Panorama_f.png https://interpharma.ch/wp-content/uploads/2022/09/Bullets_Panorama_f-1024x873.png https://www.interpharma.ch/fr/blog/serie-de-blogs-qui-finance-les-medicaments-partie-1-vaccins-contre-le-covid-19-un-succes-qui-a-son-revers/ 2026-03-03T09:52:10+00:00 https://www.interpharma.ch/wp-content/uploads/2022/08/Pipeline-COVID-19-Therapeutika-F-1.png https://www.interpharma.ch/wp-content/uploads/2026/06/Lauren-McNamer_3MB-file-size-scaled.jpg https://interpharma.ch/wp-content/uploads/2022/08/Pipeline-COVID-19-Impfstoffe-F-1024x529.png https://www.interpharma.ch/wp-content/uploads/2026/02/Susanne-Mueller_2026-scaled.jpg https://www.interpharma.ch/fr/blog/ecosysteme-de-donnees-de-sante-le-rapport-esquisse-des-pistes/ 2026-03-03T09:52:21+00:00 https://www.interpharma.ch/wp-content/uploads/2020/09/Digitalisierung-allgemein-scaled.jpg https://www.interpharma.ch/fr/blog/medienmitteilung-massnahmen-des-masterplans-2022-2026-zur-staerkung-der-biomedizinischen-forschung-und-technologie-in-der-schweiz-verpasste-chance/ 2026-03-03T09:52:29+00:00 https://www.interpharma.ch/wp-content/uploads/2022/03/iStock-1293772969.jpg https://www.interpharma.ch/fr/blog/un-signal-desastreux-en-prevision-dune-prochaine-pandemie/ 2026-03-03T09:52:38+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/blog-image-072-scaled.jpg https://www.interpharma.ch/fr/blog/medienmitteilung-gesundheitsmonitor-2022-die-pandemie-bestaetigt-die-notwendigkeit-eines-schnellen-zugangs-zu-neuen-medikamenten/ 2026-03-03T09:52:47+00:00 https://www.interpharma.ch/wp-content/uploads/2022/06/Gesundheitsmonitor-WEB-F.png https://www.interpharma.ch/fr/blog/eine-schwaechung-des-patentschutzes-waere-gefaehrlich-und-kontraproduktiv/ 2026-03-03T09:53:02+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/blog-image-066-scaled.jpg https://www.interpharma.ch/fr/blog/la-revision-de-loamal-aggrave-encore-le-probleme-dacces-des-patientes-et-patients/ 2026-03-03T09:53:25+00:00 https://www.interpharma.ch/wp-content/uploads/2022/06/Notfall.jpg https://www.interpharma.ch/fr/blog/medienmitteilung-auslandpreisvergleich-medikamente-preisdifferenz-zum-ausland-nimmt-zu-markante-preisunterscheide-auch-bei-generika-und-biosimilars/ 2026-03-03T09:53:34+00:00 https://www.interpharma.ch/wp-content/uploads/2022/05/APV-F1.png https://www.interpharma.ch/fr/blog/serie-acces-des-patients-partie-2-remboursement-de-lacces-a-linnovation-pour-assurer-que-tous-les-patients-et-patientes-en-beneficient-equitablement-et-rapidement/ 2026-03-03T09:53:48+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/blog-image-082-scaled.png https://www.interpharma.ch/wp-content/uploads/2026/02/logo-german-01-removebg-preview.png https://www.interpharma.ch/fr/blog/serie-acces-des-patients-partie-3-reponses-aux-questions-et-critiques/ 2026-03-03T09:53:59+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/blog-image-090-scaled.png https://www.interpharma.ch/fr/blog/medienmitteilung-interpharma-schlaegt-einen-rueckvergueteten-innovationszugang-fuer-patientinnen-und-patienten-vor/ 2026-03-03T09:54:19+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/blog-image-084-scaled.png https://www.interpharma.ch/fr/blog/serie-acces-des-patients-partie-1-en-suisse-lacces-des-patient-e-s-a-linnovation-est-fortement-retarde/ 2026-03-03T09:54:36+00:00 https://www.interpharma.ch/wp-content/uploads/2022/04/verz%C3%B6gerung_f.jpg https://www.interpharma.ch/fr/blog/medienmitteilung-fuehrend-in-der-entwicklung-von-mrna-medikamenten-moderna-wird-mitglied-bei-interpharma/ 2026-03-03T09:56:01+00:00 https://www.interpharma.ch/wp-content/uploads/2022/04/Annual-Conference-2022.jpeg https://www.interpharma.ch/fr/blog/medienmitteilung-wachstum-des-medikamentenmarktes-wird-durch-preissenkungen-gedaempft/ 2026-03-03T09:57:13+00:00 https://www.interpharma.ch/fr/blog/medienmitteilung-forschende-pharmaindustrie-sieht-wachsende-herausforderungen-fuer-den-standort-schweiz/ 2026-03-03T09:57:23+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/blog-image-048-scaled.jpg https://www.interpharma.ch/fr/blog/medienmitteilung-nein-zur-forschungsverbotsinitiative-interpharma-lanciert-kampagne-gegen-die-extreme-tier-und-menschenversuchsverbotsinitiative/ 2026-03-03T09:57:36+00:00 https://www.interpharma.ch/wp-content/uploads/2021/12/1117001-2.png https://www.interpharma.ch/fr/blog/la-fiabilite-de-la-suisse-en-tant-que-partenaire-contractuelle-imprudemment-compromise/ 2026-03-03T09:57:55+00:00 https://www.interpharma.ch/wp-content/uploads/2021/12/Impfstoff-Vertr%C3%A4ge.jpg https://www.interpharma.ch/fr/blog/medienmitteilung-bak-studie-zeigt-herausragende-bedeutung-der-pharmaindustrie-fuer-die-schweiz-interpharma-fordert-strategie-zur-langfristigen-sicherung-des-pharmastandortes-schweiz/ 2026-03-03T09:58:04+00:00 https://www.interpharma.ch/wp-content/uploads/2021/11/Bedeutungsstudie-21-WEB-F.png https://www.interpharma.ch/fr/blog/medienmitteilung-animal-welfare-report-2021-kontrolle-statt-verbote/ 2026-03-03T09:58:13+00:00 https://www.interpharma.ch/wp-content/uploads/2021/11/Titelbild-AWR-Web.png https://www.interpharma.ch/fr/blog/la-recherche-continue-interpharma-lance-une-campagne-de-sensibilisation/ 2026-03-03T09:58:38+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/blog-image-003.jpg https://www.interpharma.ch/fr/blog/medienmitteilung-sechs-handlungsfelder-als-grundlage-fuer-eine-kohaerente-digita-lisierungsstrategie-im-gesundheitswesen/ 2026-03-03T09:58:56+00:00 https://www.interpharma.ch/wp-content/uploads/2021/06/Erkenntnisse-aus-der-Krise.png https://www.interpharma.ch/fr/blog/pour-un-dialogue-sur-le-systeme-de-sante-et-le-pole-pharmaceutique-suisse-base-sur-les-faits/ 2026-03-03T09:59:06+00:00 https://www.interpharma.ch/wp-content/uploads/2021/09/Bild_Panorama-2021_f.png https://www.interpharma.ch/fr/blog/michele-sierro-nouvelle-porte-parole-dinterpharma-pour-la-suisse-romande/ 2026-03-03T09:59:27+00:00 https://www.interpharma.ch/wp-content/uploads/2020/02/Michele-Sierro.jpg https://www.interpharma.ch/fr/blog/medienmitteilung-fuenf-erkenntnisse-aus-der-krise-fuer-die-zukunft-des-schweizer-gesundheitswesens/ 2026-03-03T09:59:56+00:00 https://www.interpharma.ch/wp-content/uploads/2021/06/Erkenntnisse-aus-der-Krise.png https://www.interpharma.ch/fr/blog/medienmitteilung-gesundheitsmonitor-2021-covid-19-luecken-des-gesundheitssystems-werden-sichtbar-wichtige-rolle-der-pharmaindustrie-anerkannt/ 2026-03-03T10:00:10+00:00 https://www.interpharma.ch/wp-content/uploads/2021/06/Gesundheitsmonitor.png https://www.interpharma.ch/fr/blog/medienmitteilung-auslandpreisvergleich-medikamente-wechselkurse-erhoehen-die-preisunterschiede-im-vergleich-zum-ausland-generika-medikamente-werden-teurer/ 2026-03-03T10:00:20+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/blog-image-024-scaled.jpeg https://www.interpharma.ch/fr/blog/medienmitteilung-schweiz-eu-forschende-pharmaindustrie-in-der-schweiz-fordert-den-bundesrat-auf-jetzt-schnellstmoeglich-zu-handeln-und-alternativen-zu-entwickeln/ 2026-03-03T10:00:34+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/bild_schweiz-EU_kachel_380x150.jpg https://www.interpharma.ch/fr/blog/medienmitteilung-trotz-unklarem-kontext-unterstuetzen-64-der-stimmbevoelkerung-weiterhin-das-rahmenabkommen-mit-der-eu/ 2026-03-03T10:00:43+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/bild_schweiz-EU_kachel_380x150.jpg https://www.interpharma.ch/fr/blog/medienmitteilung-ein-aussetzen-der-patentrechte-ist-keine-loesung/ 2026-03-03T10:00:52+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/blog-image-074-scaled.jpg https://www.interpharma.ch/fr/blog/schweiz-eu-forschende-pharmaindustrie-in-der-schweiz-fordert-den-bundesrat-auf-schnellstmoeglich-zu-handeln/ 2026-03-03T10:01:03+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/bild_schweiz-EU_kachel_380x150.jpg https://www.interpharma.ch/fr/blog/neue-informationsuebersicht-zu-neuigkeiten-der-forschenden-pharmaindustrie-und-datenzusammenstellungen-auf-einen-blick/ 2026-03-03T10:01:16+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/blog-image-057-scaled.jpg https://www.interpharma.ch/fr/blog/medienmitteilung-interpharma-blickt-auf-das-pandemiejahr-2020-zurueck/ 2026-03-03T10:01:29+00:00 https://www.interpharma.ch/wp-content/uploads/2021/03/Jahresbericht-2020-Titelbild-E.png https://www.interpharma.ch/fr/blog/die-herstellung-von-impfstoffen-ein-komplexer-prozess/ 2026-03-03T10:01:50+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/blog-image-074-scaled.jpg https://www.interpharma.ch/fr/blog/ein-starker-pharmastandort-ist-die-beste-krisenvorsorge-2/ 2026-03-03T10:01:58+00:00 https://www.interpharma.ch/wp-content/uploads/2020/02/VD19842-scaled.jpg https://www.interpharma.ch/fr/blog/gemeinsam-gegen-covid-19-ohne-tierversuche-wird-es-weder-impfstoffe-noch-therapien-gegen-covid-19-geben/ 2026-03-03T10:02:06+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/blog-image-072-scaled.jpg https://www.interpharma.ch/fr/blog/die-verschiedenen-arten-von-impfstoffen-kurz-erklaert/ 2026-03-03T10:02:15+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/blog-image-074-scaled.jpg https://www.interpharma.ch/wp-content/uploads/2024/03/pdf24_zusammengefuegt-pdf-2.jpg https://www.interpharma.ch/fr/blog/medienmitteilung-forschende-pharmaindustrie-zieht-bilanz-ein-innovativer-pharmastandort-ist-die-beste-krisenvorsorge/ 2026-03-03T10:02:25+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/blog-image-057-scaled.jpg https://www.interpharma.ch/fr/blog/medikamentenmarkt-waechst-leicht-um-2-9/ 2026-03-03T10:02:34+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/blog-image-024-scaled.jpeg https://www.interpharma.ch/fr/blog/medienmitteilung-massstaebe-setzen-zehn-jahre-animal-welfare-charta/ 2026-03-03T10:02:53+00:00 https://www.interpharma.ch/wp-content/uploads/2020/12/AW-Report-F_Titelbild.png https://www.interpharma.ch/fr/blog/communique-de-presse-mesures-visant-a-freiner-la-hausse-des-couts-volet-2-les-modeles-de-prix-doivent-accelerer-lacces-des-patient-e-s-a-linnovation/ 2026-03-03T10:03:02+00:00 https://www.interpharma.ch/wp-content/uploads/2020/05/Bundeshaus-scaled.jpg https://www.interpharma.ch/fr/blog/le-rejet-de-linitiative-contre-les-bilaterales-est-rejouissant-il-faut-maintenant-faire-evoluer-les-relations-bilaterales/ 2026-03-03T10:03:14+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/bild_schweiz-EU_kachel_380x150.jpg https://www.interpharma.ch/fr/blog/nouveaux-faits-et-chiffres-sur-le-systeme-de-sante-et-le-paysage-pharmaceutique-suisses/ 2026-03-03T10:03:57+00:00 https://www.interpharma.ch/wp-content/uploads/2020/08/Panorama-de-la-Sante.png https://www.interpharma.ch/fr/blog/auslandpreisvergleich-medikamente-preisdifferenz-zum-ausland-bei-patentgeschuetzten-medikamenten-sinkt-weiter/ 2026-03-03T10:04:10+00:00 https://www.interpharma.ch/wp-content/uploads/2020/08/APV-Bild-1.png https://www.interpharma.ch/wp-content/uploads/2020/02/gesundheitswesen_schweiz_2019_f-komprimiert-pdf-1.jpg https://www.interpharma.ch/wp-content/uploads/2020/05/interpharma_broschure_A4_f_220322-pdf.jpg https://www.interpharma.ch/fr/blog/auslandpreisvergleich-medikamente-preisdifferenz-zum-ausland-sinkt-bei-patentgeschuetzten-medikamenten-weiter-nach-wie-vor-grosser-preisunterschied-bei-generika/ 2026-03-03T10:04:19+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/bild_schweiz-EU_kachel_380x150.jpg https://www.interpharma.ch/fr/blog/assurer-lacces-des-patients-a-linnovation/ 2026-03-03T10:04:27+00:00 https://www.interpharma.ch/wp-content/uploads/2020/07/Interpharma_Unser_Engagement_DE_lang_final-pdf.jpg https://www.interpharma.ch/fr/blog/unser-engagement-in-der-besonderen-lage-diagnostika-medikamente-impfstoffe/ 2026-03-03T10:04:36+00:00 https://www.interpharma.ch/wp-content/uploads/2020/07/Interpharma_Titelbild_Home_Icon_01-1.jpg https://www.interpharma.ch/wp-content/uploads/2020/05/Wertsch%C3%B6pfung.png https://www.interpharma.ch/fr/blog/lexcellence-scientifique-au-service-dun-secteur-economique-performant/ 2026-03-03T10:04:44+00:00 https://www.interpharma.ch/wp-content/uploads/2019/12/bak_economics_interpharma_volkswirtschaftliche_bedeutung_pharmaindustrie_f-komprimiert.pdf https://www.interpharma.ch/fr/blog/initiative-entreprises-responsables-interpharma-soutient-le-contre-projet-du-parlement/ 2026-03-03T10:05:08+00:00 https://www.interpharma.ch/fr/blog/decision-de-la-csss-n-concernant-le-1e-volet-de-mesures-visant-a-freiner-la-hausse-des-couts-interpharma-estime-quil-faut-ameliorer-larticle-sur-les-projets-pilotes/ 2026-03-03T10:06:11+00:00 https://www.interpharma.ch/fr/blog/3-questions-a-notre-nouveau-membre-mads-stoustrup-directeur-general-novo-nordisk-suisse/ 2026-03-03T10:06:28+00:00 https://www.interpharma.ch/wp-content/uploads/2020/04/WJL54596-Mats-scaled.jpg https://www.interpharma.ch/fr/blog/medienmitteilung-schweizer-bevoelkerung-erachtet-schutz-des-geistigen-eigentums-als-grundlegend-fuer-die-innovation/ 2026-03-03T10:07:31+00:00 https://www.interpharma.ch/wp-content/uploads/2022/03/iStock-1293772969.jpg https://www.interpharma.ch/fr/blog/ein-starker-pharmastandort-ist-die-beste-krisenvorsorge/ 2026-03-03T10:11:26+00:00 https://www.interpharma.ch/wp-content/uploads/2020/02/VD19842-scaled.jpg https://www.interpharma.ch/fr/blog/notre-engagement-dans-cette-situation-particuliere-5-5-place-de-production-pharmaceutique/ 2026-03-03T10:11:35+00:00 https://www.interpharma.ch/wp-content/uploads/2020/07/Interpharma_Titelbild_Home_Icon_05-1.jpg https://www.interpharma.ch/wp-content/uploads/2020/11/Animal_welfare_report_2020_final_d-pdf-1.jpg https://www.interpharma.ch/fr/blog/notre-engagement-dans-cette-situation-particuliere-4-5-recherche-et-innovation/ 2026-03-03T10:11:41+00:00 https://www.interpharma.ch/wp-content/uploads/2020/07/Interpharma_Titelbild_Home_Icon_04.jpg https://www.interpharma.ch/wp-content/uploads/2020/09/6_Polynomics_Faktenblatt_Haemophilie.pdf https://www.interpharma.ch/fr/blog/notre-engagement-dans-cette-situation-particuliere-3-5-coopereation/ 2026-03-03T10:11:48+00:00 https://www.interpharma.ch/wp-content/uploads/2020/07/Interpharma_Titelbild_Home_Icon_03-1.jpg https://www.interpharma.ch/wp-content/uploads/2020/08/gesundheitswesen.svg https://www.interpharma.ch/fr/blog/unser-engagement-in-der-besonderen-lage-2-5-versorgungssicherheit/ 2026-03-03T10:11:55+00:00 https://www.interpharma.ch/wp-content/uploads/2020/07/Interpharma_Titelbild_Home_Icon_02-1.jpg https://www.interpharma.ch/wp-content/uploads/2020/08/APV-f.png https://www.interpharma.ch/fr/blog/oui-a-la-protection-de-nos-employes-oui-a-la-loi-covid-19/ 2026-03-03T10:12:05+00:00 https://www.interpharma.ch/wp-content/uploads/2020/05/Bundeshaus-scaled.jpg https://www.interpharma.ch/fr/blog/communique-de-presse-animal-welfare-report-2023-utiliser-la-transformation-numerique-de-la-recherche-sur-les-animaux-pour-faire-avancer-les-principes-des-3r/ 2026-03-03T10:14:29+00:00 https://www.interpharma.ch/wp-content/uploads/2023/11/Animal-Welfare.jpg https://www.interpharma.ch/fr/blog/communique-de-presse-un-cercle-dexperts-presente-les-exigences-envers-une-loi-cadre-sur-la-reutilisation-des-donnees/ 2026-03-03T10:14:39+00:00 https://www.interpharma.ch/wp-content/uploads/2023/11/Digitalisierung-allgemein-1-scaled.jpg https://www.interpharma.ch/fr/blog/medienmitteilung-verhandlungsabschluss-zu-den-bilateralen-iii-ein-wichtiger-schritt-fuer-die-sicherung-von-wohlstand-und-innovationskraft-der-schweiz/ 2026-03-03T10:16:42+00:00 https://www.interpharma.ch/wp-content/uploads/2024/03/CH_EU_generisch-klein-scaled.jpg https://www.interpharma.ch/fr/blog/medienmitteilung-einreichung-der-unterschriftenlisten-ja-zur-tierversuchsfreien-zukunft-ein-erneuter-angriff-auf-den-forschungsstandort-schweiz/ 2026-03-03T10:16:52+00:00 https://www.interpharma.ch/wp-content/uploads/2022/03/iStock-1293772969.jpg https://www.interpharma.ch/fr/blog/communique-de-presse-revision-de-loamal-la-tactique-de-reduction-des-couts-menace-la-prise-en-charge-dans-les-cas-medicaux-exceptionnels/ 2026-03-03T10:18:13+00:00 https://www.interpharma.ch/wp-content/uploads/2023/01/Revision-KVVKLV_small_FR.png https://www.interpharma.ch/fr/blog/la-part-des-medicaments-dans-les-couts-de-sante-est-en-deca-des-estimations-precedentes/ 2026-03-05T07:04:58+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/blog-image-041-scaled.jpeg https://www.interpharma.ch/fr/blog/la-part-des-medicaments-dans-les-couts-de-sante-est-en-deca-des-estimations-precedentes/ 2026-03-05T07:06:14+00:00 https://www.interpharma.ch/wp-content/uploads/2018/03/AdobeStock_300795834-scaled.jpeg https://www.interpharma.ch/fr/blog/letude-davenir-suisse-confirme-la-necessite-de-reformer-lacces-pour-les-patients/ 2026-03-05T07:07:16+00:00 https://www.interpharma.ch/wp-content/uploads/2023/04/Grafik-Verzoegerung-2022-scaled.jpg https://www.interpharma.ch/fr/blog/letude-davenir-suisse-confirme-la-necessite-de-reformer-lacces-pour-les-patients/ 2026-03-05T07:09:00+00:00 https://www.interpharma.ch/wp-content/uploads/2023/04/Grafik-Verzoegerung-2022_FR-scaled.jpg https://www.interpharma.ch/fr/blog/serie-de-blogs-sur-la-conference-de-presse-annuelle-dinterpharma-partie-2-une-place-pharmaceutique-forte-un-acces-fort-des-patientes-et-patients/ 2026-03-05T07:17:11+00:00 https://www.interpharma.ch/wp-content/uploads/2023/01/Katrien-De-Vos-Kopie-scaled.jpg https://interpharma.ch/wp-content/uploads/2023/01/image-24.png https://www.interpharma.ch/fr/blog/communique-de-presse-lexpansion-des-generiques-progresse-inexorablement-en-suisse-les-nouveaux-medicaments-innovants-enregistrent-une-croissance-inferieure-a-la-moyenne/ 2026-03-05T07:51:51+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/iStock-Apotheke-scaled.jpg https://www.interpharma.ch/fr/blog/amr-awareness-week-2025-partie-3-succes-dans-la-lutte-contre-lantibioresistance/ 2026-03-12T13:36:27+00:00 https://www.interpharma.ch/fr/blog/amr-awareness-week-2025-partie-2-lavancee-insidieuse-de-lantibioresistance/ 2026-03-12T13:46:16+00:00 https://www.interpharma.ch/fr/blog/amr-awareness-week-2025-partie-3-succes-dans-la-lutte-contre-lantibioresistance/ 2026-03-12T14:11:01+00:00 https://www.interpharma.ch/fr/blog/amr-awareness-week-2025-partie-3-succes-dans-la-lutte-contre-lantibioresistance/ 2026-03-12T14:14:09+00:00 https://www.interpharma.ch/wp-content/uploads/2021/11/Blog-thumbnail-scaled.png https://www.interpharma.ch/fr/blog/amr-awareness-week-2025-partie-1-lavancee-insidieuse-de-lantibioresistance/ 2026-03-12T14:22:01+00:00 https://www.interpharma.ch/wp-content/uploads/2025/11/image-13-3.png https://interpharma.ch/wp-content/uploads/2025/11/image-12.png https://www.interpharma.ch/fr/blog/amr-awareness-week-2025-partie-1-lavancee-insidieuse-de-lantibioresistance/ 2026-03-12T14:23:37+00:00 https://www.interpharma.ch/wp-content/uploads/2021/11/Blog-thumbnail-scaled.png https://interpharma.ch/wp-content/uploads/2025/11/image-15.png https://interpharma.ch/wp-content/uploads/2025/11/image-14.png https://www.interpharma.ch/fr/blog/amr-awareness-week-2025-partie-1-lavancee-insidieuse-de-lantibioresistance/ 2026-03-12T14:24:38+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/blog-image-052.png https://interpharma.ch/wp-content/uploads/2025/11/image-17.png https://interpharma.ch/wp-content/uploads/2025/11/image-16.png https://www.interpharma.ch/fr/blog/communique-de-presse-lexpansion-des-generiques-progresse-inexorablement-en-suisse-les-nouveaux-medicaments-innovants-enregistrent-une-croissance-inferieure-a-la-moyenne/ 2026-03-16T15:58:46+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/iStock-Apotheke-scaled.jpg https://www.interpharma.ch/fr/blog/communique-de-presse-place-pharmaceutique-suisse-a-la-croisee-des-chemins-la-nouvelle-realite-geopolitique-requiert-dagir-rapidement/ 2026-03-16T16:06:50+00:00 https://www.interpharma.ch/wp-content/uploads/2020/07/F%C3%BChrend-in-Wissenschaft-und-Forschung.jpg https://www.interpharma.ch/fr/blog/episode-1-un-systeme-de-sante-fonde-sur-les-donnees/ 2026-03-17T08:34:49+00:00 https://www.interpharma.ch/wp-content/uploads/2026/03/iph-podcast.png https://www.interpharma.ch/fr/blog/episode-2-des-soins-de-sante-fiables/ 2026-03-17T08:42:35+00:00 https://www.interpharma.ch/wp-content/uploads/2026/03/iph-podcast.png https://www.interpharma.ch/fr/blog/episode-3-un-acces-rapide-et-equitable/ 2026-03-17T08:46:16+00:00 https://www.interpharma.ch/wp-content/uploads/2026/03/iph-podcast.png https://www.interpharma.ch/fr/blog/episode-4-un-secteur-de-la-sante-axe-sur-la-recherche-et-linnovation/ 2026-03-17T08:49:20+00:00 https://www.interpharma.ch/wp-content/uploads/2026/03/iph-podcast.png https://www.interpharma.ch/fr/blog/episode-6-a-patient-centred-high-quality-healthcare-system/ 2026-03-17T08:53:53+00:00 https://www.interpharma.ch/wp-content/uploads/2026/03/iph-podcast.png https://www.interpharma.ch/fr/blog/episode-7-une-politique-de-sante-globale-et-durable/ 2026-03-17T08:58:24+00:00 https://www.interpharma.ch/wp-content/uploads/2026/03/iph-podcast.png https://www.interpharma.ch/fr/blog/episode-5-limportance-de-la-responsabilite-individuelle-et-de-la-prevention/ 2026-03-17T09:02:27+00:00 https://www.interpharma.ch/wp-content/uploads/2026/03/iph-podcast.png https://www.interpharma.ch/fr/blog/episode-1-un-systeme-de-sante-fonde-sur-les-donnees/ 2026-03-17T09:09:57+00:00 https://www.interpharma.ch/wp-content/uploads/2026/03/iph-podcast.png https://www.interpharma.ch/fr/blog/episode-1-un-systeme-de-sante-fonde-sur-les-donnees/ 2026-03-17T09:12:35+00:00 https://www.interpharma.ch/wp-content/uploads/2026/03/iph-podcast.png https://www.interpharma.ch/fr/blog/episode-2-des-soins-de-sante-fiables/ 2026-03-17T09:21:45+00:00 https://www.interpharma.ch/wp-content/uploads/2026/03/iph-podcast.png https://www.interpharma.ch/fr/blog/episode-2-des-soins-de-sante-fiables/ 2026-03-17T09:24:23+00:00 https://www.interpharma.ch/wp-content/uploads/2026/03/iph-podcast.png https://www.interpharma.ch/fr/blog/episode-3-un-acces-rapide-et-equitable/ 2026-03-17T09:26:40+00:00 https://www.interpharma.ch/wp-content/uploads/2026/03/iph-podcast.png https://www.interpharma.ch/fr/blog/episode-3-un-acces-rapide-et-equitable/ 2026-03-17T09:29:02+00:00 https://www.interpharma.ch/wp-content/uploads/2026/03/iph-podcast.png https://www.interpharma.ch/fr/blog/episode-4-un-secteur-de-la-sante-axe-sur-la-recherche-et-linnovation/ 2026-03-17T09:31:13+00:00 https://www.interpharma.ch/wp-content/uploads/2026/03/iph-podcast.png https://www.interpharma.ch/fr/blog/episode-4-un-secteur-de-la-sante-axe-sur-la-recherche-et-linnovation/ 2026-03-17T09:33:34+00:00 https://www.interpharma.ch/wp-content/uploads/2026/03/iph-podcast.png https://www.interpharma.ch/fr/blog/episode-5-limportance-de-la-responsabilite-individuelle-et-de-la-prevention/ 2026-03-17T09:36:05+00:00 https://www.interpharma.ch/wp-content/uploads/2026/03/iph-podcast.png https://www.interpharma.ch/fr/blog/episode-5-limportance-de-la-responsabilite-individuelle-et-de-la-prevention/ 2026-03-17T09:38:15+00:00 https://www.interpharma.ch/wp-content/uploads/2026/03/iph-podcast.png https://www.interpharma.ch/fr/blog/episode-6-a-patient-centred-high-quality-healthcare-system/ 2026-03-17T09:43:10+00:00 https://www.interpharma.ch/wp-content/uploads/2026/03/iph-podcast.png https://www.interpharma.ch/fr/blog/episode-7-une-politique-de-sante-globale-et-durable/ 2026-03-17T09:48:22+00:00 https://www.interpharma.ch/wp-content/uploads/2026/03/iph-podcast.png https://www.interpharma.ch/fr/blog/episode-7-une-politique-de-sante-globale-et-durable/ 2026-03-17T09:50:25+00:00 https://www.interpharma.ch/wp-content/uploads/2026/03/iph-podcast.png https://www.interpharma.ch/fr/blog/episode-6-a-patient-centred-high-quality-healthcare-system/ 2026-03-17T09:54:07+00:00 https://www.interpharma.ch/wp-content/uploads/2026/03/iph-podcast.png https://www.interpharma.ch/fr/blog/3-questions-a-nos-nouveaux-vice-chair-du-comite-place-suisse-bairbre-hickie-general-manager-suisse-takeda/ 2026-03-23T14:24:23+00:00 https://www.interpharma.ch/wp-content/uploads/2026/01/BAIRBRE_HICKIE_DSC8736-1-scaled.jpg https://interpharma.ch/wp-content/uploads/2026/01/BAIRBRE_HICKIE_DSC8736-1024x768.jpg https://www.interpharma.ch/fr/blog/medienmitteilung-tag-der-pharmazeutischen-industrie-2026-pharmastandort-schweiz-am-scheideweg/ 2026-03-24T11:52:03+00:00 https://www.interpharma.ch/wp-content/uploads/2026/03/Interpharma_home_hero.webp https://www.interpharma.ch/fr/blog/les-accords-bilateraux-iii-assurent-que-la-suisse-reste-sur-la-voie-du-succes/ 2026-04-15T11:10:18+00:00 https://www.interpharma.ch/wp-content/uploads/2025/07/CH_EU_generisch-klein-scaled.jpg https://www.interpharma.ch/fr/blog/acces-aux-medicaments-innovants-la-suisse-continue-de-stagner-derriere-lallemagne/ 2026-05-19T07:15:23+00:00 https://www.interpharma.ch/wp-content/uploads/2026/05/Screenshot-2026-05-18-122934.png https://www.interpharma.ch/wp-content/uploads/2026/05/Screenshot-2026-05-18-122934.png https://www.interpharma.ch/wp-content/uploads/2026/05/260518_WAIT_Hist.Entwicklung.png https://www.interpharma.ch/fr/blog/acces-aux-medicaments-innovants-la-suisse-continue-de-stagner-derriere-lallemagne/ 2026-05-19T07:16:03+00:00 https://www.interpharma.ch/wp-content/uploads/2026/05/Screenshot-2026-05-18-122934.png https://www.interpharma.ch/wp-content/uploads/2026/05/260518_WAIT_Hist.Entwicklung_EN.png https://www.interpharma.ch/fr/blog/acces-aux-medicaments-innovants-la-suisse-continue-de-stagner-derriere-lallemagne/ 2026-05-19T07:16:22+00:00 https://www.interpharma.ch/wp-content/uploads/2026/05/Screenshot-2026-05-18-122934.png https://www.interpharma.ch/wp-content/uploads/2026/05/260518_WAIT_Hist.Entwicklung_F.png https://www.interpharma.ch/fr/blog/communique-de-presse-revision-de-loamal-reevaluation-plutot-que-mise-en-oeuvre-precipitee/ 2026-05-22T07:45:55+00:00 https://www.interpharma.ch/wp-content/uploads/2020/05/Bundeshaus-scaled.jpg https://www.interpharma.ch/fr/blog/medienmitteilung-tag-der-pharmazeutischen-industrie-2026-pharmastandort-schweiz-am-scheideweg/ 2026-05-22T07:46:21+00:00 https://www.interpharma.ch/wp-content/uploads/2026/03/Interpharma_home_hero.webp https://www.interpharma.ch/fr/blog/3-questions-a-nos-nouveaux-vice-chair-du-comite-place-suisse-bairbre-hickie-general-manager-suisse-takeda/ 2026-05-22T07:47:14+00:00 https://www.interpharma.ch/wp-content/uploads/2026/01/BAIRBRE_HICKIE_DSC8736-1-scaled.jpg https://interpharma.ch/wp-content/uploads/2026/01/BAIRBRE_HICKIE_DSC8736-3-1024x768.jpg https://www.interpharma.ch/fr/blog/communique-de-presse-graves-risques-pour-la-prise-en-charge-de-la-population-interpharma-rejette-la-revision-de-loamal/ 2026-05-22T08:30:12+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/blog-image-053-scaled.jpg https://www.interpharma.ch/fr/blog/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-julian-bertschinger-head-emea-external-scientific-innovation-johnson-johnson/ 2026-06-05T14:12:30+00:00 https://www.interpharma.ch/wp-content/uploads/2026/06/Julian-Bertschinger_1.png https://www.interpharma.ch/wp-content/uploads/2026/06/Julian-Bertschinger_1-1.png https://www.interpharma.ch/fr/blog/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-julian-bertschinger-head-emea-external-scientific-innovation-johnson-johnson/ 2026-06-05T14:12:32+00:00 https://www.interpharma.ch/wp-content/uploads/2026/06/Julian-Bertschinger_1.png https://www.interpharma.ch/wp-content/uploads/2026/06/Julian-Bertschinger_1-2.png https://www.interpharma.ch/fr/blog/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-lauren-mcnamer-general-manager-de-lilly-switzerland/ 2026-06-10T15:17:39+00:00 https://www.interpharma.ch/wp-content/uploads/2026/06/Lauren-McNamer_3MB-file-size-scaled.jpg https://www.interpharma.ch/wp-content/uploads/2026/06/Lauren-McNamer_3MB-file-size-scaled.jpg https://www.interpharma.ch/fr/blog/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-lauren-mcnamer-general-manager-de-lilly-switzerland/ 2026-06-10T15:17:41+00:00 https://www.interpharma.ch/wp-content/uploads/2026/06/Lauren-McNamer_3MB-file-size-scaled.jpg https://www.interpharma.ch/wp-content/uploads/2026/06/Lauren-McNamer_3MB-file-size-scaled.jpg https://www.interpharma.ch/fr/blog/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-lauren-mcnamer-general-manager-de-lilly-switzerland/ 2026-06-10T15:17:42+00:00 https://www.interpharma.ch/wp-content/uploads/2026/06/Lauren-McNamer_3MB-file-size-scaled.jpg https://www.interpharma.ch/wp-content/uploads/2026/06/Lauren-McNamer_3MB-file-size-scaled.jpg https://www.interpharma.ch/fr/blog/les-accords-bilateraux-iii-assurent-que-la-suisse-reste-sur-la-voie-du-succes/ 2026-06-15T09:50:16+00:00 https://www.interpharma.ch/wp-content/uploads/2025/07/CH_EU_generisch-klein-scaled.jpg https://www.interpharma.ch/fr/blog/communique-de-presse-enquete-sur-leurope-2026-toujours-un-large-soutien-aux-accords-bilateraux/ 2026-06-16T12:49:22+00:00 https://www.interpharma.ch/wp-content/uploads/2025/07/CH_EU_generisch-klein-scaled.jpg https://www.interpharma.ch/fr/blog/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-rea-lal-country-lead-de-pfizer-switzerland/ 2026-06-17T14:35:20+00:00 https://www.interpharma.ch/wp-content/uploads/2026/06/Reas-Portrait.jpg https://www.interpharma.ch/wp-content/uploads/2026/06/Reas-Portrait-1.jpg https://www.interpharma.ch/fr/blog/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-rea-lal-country-lead-de-pfizer-switzerland/ 2026-06-17T14:35:23+00:00 https://www.interpharma.ch/wp-content/uploads/2026/06/Reas-Portrait.jpg https://www.interpharma.ch/wp-content/uploads/2026/06/Reas-Portrait.jpg https://www.interpharma.ch/fr/blog/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-jerome-garcin-general-manager-for-switzerland-and-austria-bristol-myers-squibb/ 2026-06-22T11:42:21+00:00 https://www.interpharma.ch/wp-content/uploads/2026/05/Jerome_Garcin_%C2%A9-BMS-Switzerland-2.jpg https://www.interpharma.ch/wp-content/uploads/2026/05/Jerome_Garcin_%C2%A9-BMS-Switzerland-edited.jpg https://www.interpharma.ch/fr/blog/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-jerome-garcin-general-manager-for-switzerland-and-austria-bristol-myers-squibb/ 2026-06-22T11:43:46+00:00 https://www.interpharma.ch/wp-content/uploads/2026/05/Jerome_Garcin_%C2%A9-BMS-Switzerland-2.jpg https://www.interpharma.ch/wp-content/uploads/2026/05/Jerome_Garcin_%C2%A9-BMS-Switzerland-edited.jpg https://www.interpharma.ch/fr/blog/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-jerome-garcin-general-manager-for-switzerland-and-austria-bristol-myers-squibb/ 2026-06-22T11:46:19+00:00 https://www.interpharma.ch/wp-content/uploads/2026/05/Jerome_Garcin_%C2%A9-BMS-Switzerland-2.jpg https://www.interpharma.ch/wp-content/uploads/2026/05/Jerome_Garcin_%C2%A9-BMS-Switzerland-edited.jpg https://www.interpharma.ch/fr/blog/communique-de-presse-enquete-sur-leurope-2026-toujours-un-large-soutien-aux-accords-bilateraux/ 2026-06-22T13:46:30+00:00 https://www.interpharma.ch/wp-content/uploads/2025/07/CH_EU_generisch-klein-scaled.jpg https://www.interpharma.ch/fr/blog/communique-de-presse-graves-risques-pour-la-prise-en-charge-de-la-population-interpharma-rejette-la-revision-de-loamal/ 2026-06-22T13:46:47+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/blog-image-053-scaled.jpg https://www.interpharma.ch/fr/blog/medienmitteilung-tag-der-pharmazeutischen-industrie-2026-pharmastandort-schweiz-am-scheideweg/ 2026-06-22T13:47:04+00:00 https://www.interpharma.ch/wp-content/uploads/2026/03/Interpharma_home_hero.webp https://www.interpharma.ch/fr/blog/communique-de-presse-revision-de-loamal-reevaluation-plutot-que-mise-en-oeuvre-precipitee/ 2026-06-22T13:47:21+00:00 https://www.interpharma.ch/wp-content/uploads/2020/05/Bundeshaus-scaled.jpg https://www.interpharma.ch/fr/blog/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-rea-lal-country-lead-de-pfizer-switzerland/ 2026-06-24T08:01:40+00:00 https://www.interpharma.ch/wp-content/uploads/2026/06/Reas-Portrait.jpg https://www.interpharma.ch/wp-content/uploads/2026/06/Reas-Portrait-2.jpg https://www.interpharma.ch/fr/?p=16724 2026-06-26T10:14:56+00:00 https://www.interpharma.ch/wp-content/uploads/2026/03/ABBVIE_Michele-Ravara.jpg https://www.interpharma.ch/wp-content/uploads/2026/06/ABBVIE_Michele-Ravara_90432-1.jpg https://www.interpharma.ch/fr/?p=16724 2026-06-26T10:15:31+00:00 https://www.interpharma.ch/wp-content/uploads/2026/03/ABBVIE_Michele-Ravara.jpg https://www.interpharma.ch/wp-content/uploads/2026/03/ABBVIE_Michele-Ravara.jpg https://www.interpharma.ch/fr/blog/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-julian-bertschinger-head-emea-external-scientific-innovation-johnson-johnson/ 2026-06-26T12:15:11+00:00 https://www.interpharma.ch/wp-content/uploads/2026/06/Julian-Bertschinger_1.png https://www.interpharma.ch/wp-content/uploads/2026/06/Julian-Bertschinger_1.png